— Know what they know.
Not Investment Advice

INMB NASDAQ

INmune Bio, Inc.
1W: -7.1% 1M: -29.6% 3M: -16.4% YTD: -7.1% 1Y: -20.1% 3Y: -80.9% 5Y: -92.3%
$1.52
+0.09 (+6.29%)
 
Weekly Expected Move ±6.7%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 25 · $39.7M mcap · 23M float · 2.60% daily turnover · Short 52% of daily vol
Credit Risk of going bust: lower than 52% of companies Debt: 3.4% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.01 (down 99.5%), INmune Bio, Inc. would be worth roughly what it owes.
Total debt $1.4M against a stock market value of $39.7M.
Distance to default 5.37 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $702K (short-term plus half of long-term), stock volatility 72.7%; Altman Z'' -23.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
#624 of 1061
Biotechnology
Healthcare · Micro Cap · 778 peers
Market Share
0.0%
Top 4 Concentration: 22.6%

Technical Signal Map

100 Bullish
38 Neutral
641 Bearish
INMB $40M
INmune Bio, Inc.
BEARISH -87
SGP $950M
SpyGlass Pharma, Inc. Common Stock
BULLISH +100
VSTM $910M
Verastem, Inc.
BULLISH +100
SOLTF $770M
Nxera Pharma Co., Ltd.
BULLISH +100
GRDX $40M
GridAI Technologies Corp.
BULLISH +100
ENTX $510M
Entera Bio Ltd.
BULLISH +91
ATNM $50M
Actinium Pharmaceuticals, Inc.
BULLISH +91
XFOR $320M
X4 Pharmaceuticals, Inc.
BULLISH +87
ESLA $40M
Estrella Immunopharma, Inc.
BULLISH +87
KRRO $180M
Korro Bio, Inc.
BULLISH +84
HURA $140M
TuHURA Biosciences, Inc.
BULLISH +84
ZIVO $20M
ZIVO Bioscience, Inc.
BULLISH +78
RIGL $900M
Rigel Pharmaceuticals, Inc.
BULLISH +75
CING $70M
Cingulate Inc.
BULLISH +73
AGTX —
Agentix Corp.
BULLISH +73
ACUT —
Accustem Sciences Inc.
BULLISH +68
XNCR $1.9B
Xencor, Inc.
BULLISH +66
KLRA $1.7B
Kailera Therapeutics, Inc.
BULLISH +66
TRAX $1.6B
First Tracks Biotherapeutics Inc
BULLISH +66
LBRX $1.2B
LB Pharmaceuticals Inc Common Stock
BULLISH +66
SLN $930M
Silence Therapeutics plc
BULLISH +66
PBYI $570M
Puma Biotechnology, Inc.
BULLISH +66
MXCT $140M
MaxCyte, Inc.
BULLISH +66
IRLA $30M
IRulya Therapeutics Inc.
BULLISH +65
MBXBF $30M
Microbix Biosystems Inc.
BULLISH +65
BOLT $10M
Bolt Biotherapeutics, Inc.
BULLISH +62
AZTR —
Azitra, Inc.
BULLISH +62
BDRX —
Biodexa Pharmaceuticals Plc
BULLISH +62
CBDG —
THC Farmaceuticals, Inc.
BULLISH +60
PHAR $710M
Pharming Group N.V.
BULLISH +59
INDP $360M
Indaptus Therapeutics, Inc.
BULLISH +59
ANIX $100M
Anixa Biosciences, Inc.
BULLISH +59
NRXS $90M
NeurAxis, Inc.
BULLISH +59
OABIW $1.1B
OmniAb, Inc.
BULLISH +58
DMAC $470M
DiaMedica Therapeutics Inc.
BULLISH +58
SCNLF $170M
Scancell Holdings plc
BULLISH +58
ICCC $90M
ImmuCell Corporation
BULLISH +58
SPTX $1.1B
Seaport Therapeutics, Inc. Common Stock
BULLISH +55
CASBF $1.4B
CanSino Biologics Inc.
BULLISH +52
BRVE $1.5B
Braveheart Bio, Inc.
BULLISH +51
TXTM $90M
ProText Mobility, Inc.
BULLISH +51
IMNN $10M
Imunon, Inc.
BULLISH +51
HALB —
Halberd Corporation
BULLISH +51
SEPN $1.9B
Septerna Inc
BULLISH +50
MAZE $1.7B
Maze Therapeutics, Inc.
BULLISH +50
COAG $1.6B
Hemab Therapeutics Holdings, Inc. Common Stock
BULLISH +50
CRMD $610M
CorMedix Inc.
BULLISH +50
PYPD $110M
PolyPid Ltd.
BULLISH +50
ADCT $180M
ADC Therapeutics S.A.
BULLISH +49
NYMXF $10M
Nymox Pharmaceutical Corporation
BULLISH +47
PRME $670M
Prime Medicine, Inc.
BULLISH +44
NAUT $410M
Nautilus Biotechnolgy, Inc.
BULLISH +44
TCRT $10M
Alaunos Therapeutics, Inc.
BULLISH +44
RARE $1.5B
Ultragenyx Pharmaceutical Inc.
BULLISH +43
IUGNF $30M
Imugene Limited
BULLISH +43
PCSA $10M
Processa Pharmaceuticals, Inc.
BULLISH +43
HEPA —
Hepion Pharmaceuticals, Inc.
BULLISH +43
IMCR $1.6B
Immunocore Holdings plc
BULLISH +41
XERS $1.9B
Xeris Biopharma Holdings, Inc.
BULLISH +40
VSBC $10M
VitaSpring Biomedical Co. Ltd.
BULLISH +40
IPIX —
Innovation Pharmaceuticals Inc.
BULLISH +38
IMUC $10M
EOM Pharmaceuticals Holdings, Inc.
BULLISH +36
NBTX $1.5B
Nanobiotix S.A.
BULLISH +35
CKDXF $10M
Ceryvyn Therapeutics Ltd
BULLISH +35
ZEOX $10M
Zeo ScientifiX, Inc.
BULLISH +35
CYYNF —
Cynata Therapeutics Limited
BULLISH +35
DMRA $1.3B
Damora Therapeutics, Inc.
BULLISH +34
VIR $1.8B
Vir Biotechnology, Inc.
BULLISH +33
SLGL $230M
Sol-Gel Technologies Ltd.
BULLISH +33
CYDY $380M
CytoDyn Inc.
BULLISH +31
PDSB $60M
PDS Biotechnology Corporation
BULLISH +30
ABOS $140M
Acumen Pharmaceuticals, Inc.
LEAN BULL +27
HOWL $50M
Werewolf Therapeutics, Inc.
LEAN BULL +27
ATOS $30M
Atossa Therapeutics, Inc.
LEAN BULL +27
ARDS —
Aridis Pharmaceuticals, Inc.
LEAN BULL +27
INFIQ —
Infinity Pharmaceuticals, Inc.
LEAN BULL +27
PPCB —
Propanc Biopharma, Inc.
LEAN BULL +27
BSSP —
Baseline Productions, Inc.
LEAN BULL +27
PTCHF $390M
PureTech Health plc
LEAN BULL +26
ACHFF $40M
Arch Biopartners Inc.
LEAN BULL +26
PRVCF $10M
PreveCeutical Medical Inc.
LEAN BULL +26
SGMT $310M
Sagimet Biosciences Inc.
LEAN BULL +25
ABPO —
Abpro Holdings, Inc.
LEAN BULL +24
MLTX $1.0B
MoonLake Immunotherapeutics
LEAN BULL +23
NTRR —
Neutra Corp.
LEAN BULL +20
PXMD —
PaxMedica, Inc. Common Stock
LEAN BULL +18
BTAX —
Biostax Corp.
LEAN BULL +18
LYRA —
Lyra Therapeutics, Inc.
LEAN BULL +18
REVB —
Revelation Biosciences, Inc.
LEAN BULL +18
NNVC $40M
NanoViricides, Inc.
LEAN BULL +15
HSTC $210M
HST Global, Inc.
LEAN BULL +13
EVAX $20M
Evaxion Biotech A/S
LEAN BULL +13
OCEA —
Ocean Biomedical, Inc.
LEAN BULL +13
RXRX $2.0B
Recursion Pharmaceuticals, Inc.
LEAN BULL +12
ENSC $10M
Ensysce Biosciences, Inc.
LEAN BULL +12
LCTX $250M
Lineage Cell Therapeutics, Inc.
LEAN BULL +11
GDTC $10M
CytoMed Therapeutics Limited
LEAN BULL +11
OKYO $70M
OKYO Pharma Limited
LEAN BULL +10
MBRX $10M
Moleculin Biotech, Inc.
LEAN BULL +10
DNAG —
DNAPrint Genomics, Inc.
LEAN BULL +10
RBSH —
Rebus Holdings, Inc.
LEAN BULL +10
OBX $10M
Obsidian Therapeutics Inc.
NEUTRAL +9
STAB —
Statera Biopharma, Inc.
NEUTRAL +8
LYEL $230M
Lyell Immunopharma, Inc.
NEUTRAL +7
PRLD $210M
Prelude Therapeutics Incorporated
NEUTRAL +7
NMAD $50M
NOMAD Power Solutions, Inc.
NEUTRAL +5
CNBX —
CNBX Pharmaceuticals Inc.
NEUTRAL +4
CALC —
CalciMedica, Inc.
NEUTRAL +4
NWBO $260M
Northwest Biotherapeutics, Inc.
NEUTRAL +2
MLLCF $150M
Molecular Partners AG
NEUTRAL +2
EHOS —
Ehouse Global, Inc.
NEUTRAL +2
HESG —
Health Sciences Group, Inc.
NEUTRAL +2
REPL $1.1B
Replimune Group, Inc.
NEUTRAL +1
RGIN —
Regenicin, Inc.
NEUTRAL +1
RCAR —
RenovaCare, Inc.
NEUTRAL +1
NMTRQ —
9 Meters Biopharma, Inc.
NEUTRAL +1
CFRXQ —
ContraFect Corp.
NEUTRAL +1
LYCA $1.6B
Lycia Therapeutics Inc.
N/A 0
CTY $200M
City Therapeutics Inc.
N/A 0
IAM $130M
Iambic Therapeutics Inc.
N/A 0
LONA $20M
LeonaBio, Inc.
NEUTRAL 0
JUNS —
Jupiter Neurosciences, Inc.
NEUTRAL 0
PHMMF $1.6B
Pharma Mar, S.A.
NEUTRAL -3
SRZN $190M
Surrozen, Inc.
NEUTRAL -3
KLDO —
Kaleido Biosciences, Inc.
NEUTRAL -5
YARW $180M
Yarrow Bioscience Inc
NEUTRAL -6
ELUT $40M
Elutia Inc
NEUTRAL -6
GSTC —
GlobeStar Therapeutics Corporation
NEUTRAL -6
BPTH —
Bio-Path Holdings, Inc.
NEUTRAL -6
ABVC $30M
ABVC BioPharma, Inc.
NEUTRAL -7
USRM —
U.S. Stem Cell, Inc.
NEUTRAL -7
VCRE $260M
Vicore Pharma Holding AB
NEUTRAL -8
KROS $220M
Keros Therapeutics, Inc.
NEUTRAL -8
ENGNW $10M
enGene Holdings Inc. Warrants
NEUTRAL -8
PULM $10M
Pulmatrix, Inc.
NEUTRAL -8
ANAB $1.5B
AnaptysBio, Inc.
NEUTRAL -9
MRPI —
Mera Pharmaceuticals, Inc.
NEUTRAL -9
KNBIF —
Kane Biotech Inc.
NEUTRAL -9
LIANY —
LianMedical
NEUTRAL -9
ODTX $940M
Odyssey Therapeutics, Inc.
LEAN BEAR -11
INRLF $640M
Valneva SE
LEAN BEAR -12
POLBF $70M
Poolbeg Pharma PLC
LEAN BEAR -12
CLYYF $10M
Celyad Oncology S.A.
LEAN BEAR -12
PLUR $10M
Pluri Inc.
LEAN BEAR -13
GBIM —
GlobeImmune, Inc.
LEAN BEAR -13
INVA $1.5B
Innoviva, Inc.
LEAN BEAR -15
MDNAF $20M
Medicenna Therapeutics Corp.
LEAN BEAR -15
ONCSQ —
OncoSec Medical Incorporated
LEAN BEAR -15
BIXT —
Bioxytran, Inc.
LEAN BEAR -15
NKGN —
NKGen Biotech, Inc.
LEAN BEAR -16
HLSQ —
Tessera Defense and Homeland Security Inc
LEAN BEAR -16
EMMA —
Emmaus Life Sciences, Inc.
LEAN BEAR -16
REPCF —
RepliCel Life Sciences Inc.
LEAN BEAR -16
MCET —
MultiCell Technologies, Inc.
LEAN BEAR -16
CMND —
Clearmind Medicine Inc.
LEAN BEAR -16
NURPF $1.8B
Neuren Pharmaceuticals Limited
LEAN BEAR -17
DTIL $180M
Precision BioSciences, Inc.
LEAN BEAR -17
PEPG $170M
PepGen Inc.
LEAN BEAR -17
MMIRF $30M
MedMira Inc.
LEAN BEAR -17
JBIO $930M
Jade Biosciences, Inc.
LEAN BEAR -18
ACRS $550M
Aclaris Therapeutics, Inc.
LEAN BEAR -18
PARD —
Poniard Pharmaceuticals, Inc.
LEAN BEAR -18
KRSA $150M
Korsana Biosciences, Inc.
LEAN BEAR -20
AOBI —
American Oriental Bioengineering, Inc.
LEAN BEAR -20
TYRA $1.2B
Tyra Biosciences, Inc.
LEAN BEAR -22
IMMB —
Immunotech Laboratories, Inc.
LEAN BEAR -22
FPMI —
FluoroPharma Medical, Inc.
LEAN BEAR -22
GBLX —
GB Sciences, Inc.
LEAN BEAR -22
ZBIO $1.8B
Zenas BioPharma, Inc.
LEAN BEAR -24
ENTA $340M
Enanta Pharmaceuticals, Inc.
LEAN BEAR -24
APLMW $170M
Apollomics, Inc.
LEAN BEAR -24
ARMP $140M
Armata Pharmaceuticals, Inc.
LEAN BEAR -24
NTHI $90M
Neonc Technologies Holdings, Inc.
LEAN BEAR -24
SRBCF —
Sirona Biochem Corp.
LEAN BEAR -24
PZRXQ —
PhaseRx, Inc.
LEAN BEAR -24
RNAZ —
TransCode Therapeutics, Inc.
LEAN BEAR -24
NNBP —
Nanobac Pharmaceuticals, Incorporated
LEAN BEAR -24
NNLX —
NanoLogix, Inc.
LEAN BEAR -24
CLAZF —
Claritas Pharmaceuticals, Inc.
LEAN BEAR -24
IMVIF —
IMV Inc.
LEAN BEAR -24
PREDQ —
Predictive Discovery Limited
LEAN BEAR -24
FGHQF $360M
Frontage Holdings Corporation
LEAN BEAR -25
GWIN $360M
Glorywin Entertainment Group, Inc.
LEAN BEAR -25
SPHRY $220M
Starpharma Holdings Limited
LEAN BEAR -25
KNTPF $120M
Kintor Pharmaceutical Limited
LEAN BEAR -25
LVCLF $20M
Algorae Pharmaceuticals Limited
LEAN BEAR -25
BCLI $10M
Brainstorm Cell Therapeutics Inc.
LEAN BEAR -25
QPTFF $10M
Quest PharmaTech Inc.
LEAN BEAR -25
FORU —
ForU Holdings, Inc.
LEAN BEAR -25
CHNXF —
ChitogenX Inc.
LEAN BEAR -25
CLGN —
CollPlant Biotechnologies Ltd.
LEAN BEAR -25
VINC —
Vincerx Pharma, Inc.
LEAN BEAR -25
ALEC $200M
Alector, Inc.
LEAN BEAR -26
RLYB $90M
Rallybio Corporation
LEAN BEAR -26
AEON $10M
AEON Biopharma, Inc.
LEAN BEAR -26
ATXI —
Avenue Therapeutics, Inc.
LEAN BEAR -26
STOK $1.6B
Stoke Therapeutics, Inc.
LEAN BEAR -27
CURX $10M
Curanex Pharmaceuticals Inc Common Stock
LEAN BEAR -27
ENZC —
Enzolytics Inc.
BEARISH -30
AVLN $1.1B
Avalyn Pharma Inc. Common Stock
BEARISH -31
DBVT $230M
DBV Technologies S.A.
BEARISH -31
RNA $140M
Atrium Therapeutics, Inc.
BEARISH -31
PBIGF $10M
Paradigm Biopharmaceuticals Limited
BEARISH -31
PKTX —
ProtoKinetix, Incorporated
BEARISH -31
CARM —
Carisma Therapeutics, Inc.
BEARISH -31
TRVN —
Trevena, Inc.
BEARISH -31
DRUG $520M
Bright Minds Biosciences Inc.
BEARISH -32
TRDA $170M
Entrada Therapeutics, Inc.
BEARISH -32
BDTX $110M
Black Diamond Therapeutics, Inc.
BEARISH -32
INNMF $30M
Amplia Therapeutics Limited
BEARISH -32
KPTI $10M
Karyopharm Therapeutics Inc.
BEARISH -32
AAGH —
America Great Health
BEARISH -32
BXRXQ —
Baudax Bio, Inc.
BEARISH -32
ADXN —
Addex Therapeutics Ltd
BEARISH -32
ABSI $1.6B
Absci Corporation
BEARISH -33
SNBIF $1.3B
SanBio Company Limited
BEARISH -33
FATE $250M
Fate Therapeutics, Inc.
BEARISH -33
DYAI $20M
Dyadic International, Inc.
BEARISH -33
BIVI $10M
BioVie Inc.
BEARISH -33
LSTA $10M
Lisata Therapeutics, Inc.
BEARISH -33
XCUR $10M
Exicure, Inc.
BEARISH -33
VRCI —
Verde Science, Inc.
BEARISH -33
HLUN —
HEALTHeUNIVERSE, Inc.
BEARISH -33
SNNAQ —
Sienna Biopharmaceuticals, Inc.
BEARISH -33
NTII —
Neurobiological Technologies, Inc.
BEARISH -33
CMRA —
Comera Life Sciences Holdings, Inc.
BEARISH -33
HAVLF —
HAVN Life Sciences Inc.
BEARISH -33
GLSHQ —
Gelesis Holdings, Inc.
BEARISH -33
PSYBF —
PsyBio Therapeutics Corp
BEARISH -33
MRZM —
Marizyme, Inc.
BEARISH -33
TLOG —
TetraLogic Pharmaceuticals Corporation
BEARISH -33
NTLA $1.6B
Intellia Therapeutics, Inc.
BEARISH -34
JANX $1.0B
Janux Therapeutics, Inc.
BEARISH -34
BPMUF $960M
Basilea Pharmaceutica AG
BEARISH -34
BETRF $110M
BetterLife Pharma Inc.
BEARISH -34
SYGGF —
Synairgen plc
BEARISH -34
VAXX —
Vaxxinity, Inc.
BEARISH -34
PVLA $1.8B
Palvella Therapeutics, Inc.
BEARISH -35
IFRX $230M
InflaRx N.V.
BEARISH -35
ATGGF $140M
Actinogen Medical Limited
BEARISH -35
SQZB —
SQZ Biotechnologies Company
BEARISH -35
MEOBF $2.0B
Mesoblast Limited
BEARISH -37
CLNN $60M
Clene Inc.
BEARISH -39
CEROW —
CERo Therapeutics Holdings, Inc.
BEARISH -39
OCS $490M
Oculis Holding AG
BEARISH -40
ALXO $160M
ALX Oncology Holdings Inc.
BEARISH -40
FBIOP $130M
Fortress Biotech, Inc.
BEARISH -40
FHTX $120M
Foghorn Therapeutics Inc.
BEARISH -40
AURX $60M
Nuo Therapeutics, Inc.
BEARISH -40
VRPX —
Virpax Pharmaceuticals, Inc.
BEARISH -40
PBMWW —
Psyence Biomedical Ltd. Warrant
BEARISH -40
JAGX —
Jaguar Health, Inc.
BEARISH -40
HTDS —
Hard to Treat Diseases Inc.
BEARISH -40
CALA —
Calithera Biosciences, Inc.
BEARISH -40
KARD $1.1B
Kardigan, Inc.
BEARISH -41
PPTDF $870M
PeptiDream Inc.
BEARISH -41
EQ $80M
Equillium, Inc.
BEARISH -41
LOBEF $10M
Lobe Sciences Ltd.
BEARISH -41
SNTI $10M
Senti Biosciences, Inc.
BEARISH -41
SRPT $1.9B
Sarepta Therapeutics, Inc.
BEARISH -42
CSPHF $1.4B
CStone Pharmaceuticals
BEARISH -42
DRTSW $1.2B
Alpha Tau Medical Ltd.
BEARISH -42
OVID $420M
Ovid Therapeutics Inc.
BEARISH -42
NGNE $370M
Neurogene Inc.
BEARISH -42
DTCFF $20M
Defence Therapeutics Inc.
BEARISH -42
MRKR $20M
Marker Therapeutics, Inc.
BEARISH -42
PROT —
Proteonomix, Inc.
BEARISH -42
SIGY —
Sigyn Therapeutics, Inc.
BEARISH -42
BRAXF —
Braxia Scientific Corp.
BEARISH -42
EFTR —
eFFECTOR Therapeutics, Inc.
BEARISH -42
RNUGF —
ReNeuron Group plc
BEARISH -42
PANC —
Panacos Pharmaceuticals, Inc.
BEARISH -42
SYVC —
Synovics Pharmaceuticals, Inc.
BEARISH -42
CDXI —
Cardax, Inc.
BEARISH -42
PFND —
Pathfinder Cell Therapy, Inc.
BEARISH -42
NBIO —
Nascent Biotech, Inc.
BEARISH -42
ADYX —
Adynxx, Inc.
BEARISH -42
LADX —
LadRx Corporation
BEARISH -43
RAPP $1.2B
Rapport Therapeutics, Inc. Common Stock
BEARISH -44
CGEM $880M
Cullinan Therapeutics, Inc.
BEARISH -44
VICP $10M
Vicapsys Life Sciences, Inc.
BEARISH -44
CNSP $10M
CNS Pharmaceuticals, Inc.
BEARISH -44
ADRX $1.9B
ADARx Pharmaceuticals, Inc.
BEARISH -46
CASIF —
CASI Pharmaceuticals, Inc.
BEARISH -46
CRVS $890M
Corvus Pharmaceuticals, Inc.
BEARISH -48
GLSI $240M
Greenwich LifeSciences, Inc.
BEARISH -48
ADAPY $10M
Adaptimmune Therapeutics plc
BEARISH -48
TSHA $1.3B
Taysha Gene Therapies, Inc.
BEARISH -49
ARVN $470M
Arvinas, Inc.
BEARISH -49
PRTA $420M
Prothena Corporation plc
BEARISH -49
CCCC $380M
C4 Therapeutics, Inc.
BEARISH -49
ELTX $40M
Elicio Therapeutics, Inc.
BEARISH -49
DVHGF $20M
Devonian Health Group, Inc.
BEARISH -49
LEXX $10M
Lexaria Bioscience Corp.
BEARISH -49
ALLR $10M
Allarity Therapeutics, Inc.
BEARISH -49
ANEB $10M
Anebulo Pharmaceuticals, Inc.
BEARISH -49
SCPS —
Scopus BioPharma Inc.
BEARISH -49
RLFTY —
MindMaze Therapeutics Holding S.A.
BEARISH -49
BITRF —
Biotron Limited
BEARISH -49
BIORQ —
Biora Therapeutics, Inc.
BEARISH -49
SLXN —
Silexion Therapeutics Ltd.
BEARISH -49
THER —
Theralink Technologies, Inc.
BEARISH -49
AAPG $1.4B
Ascentage Pharma Group International
BEARISH -50
EDIT $370M
Editas Medicine, Inc.
BEARISH -50
TTRX $310M
Turn Therapeutics Inc.
BEARISH -50
NTRB $70M
Nutriband Inc.
BEARISH -50
CSBR $70M
Champions Oncology, Inc.
BEARISH -50
HRGN $30M
Harvard Apparatus Regenerative Technology Inc.
BEARISH -50
JSPR $20M
Jasper Therapeutics, Inc.
BEARISH -50
APUS —
Apimeds Pharmaceuticals US, Inc
BEARISH -50
IBOGF —
Universal Ibogaine Inc.
BEARISH -50
ERNA —
Ernexa Therapeutics Inc.
BEARISH -50
VRAX —
Virax Biolabs Group Limited
BEARISH -50
PHRRF —
PharmaTher Holdings Ltd.
BEARISH -50
MRES —
Institute of Biomedical Research Corp.
BEARISH -50
SCNI —
Scinai Immunotherapeutics Ltd.
BEARISH -50
DNA $670M
Ginkgo Bioworks Holdings, Inc.
BEARISH -51
INKT $50M
MiNK Therapeutics, Inc.
BEARISH -51
HOPHF $20M
Hemogenyx Pharmaceuticals Plc
BEARISH -52
HNSBF $330M
Hansa Biopharma AB (publ)
BEARISH -53
INTI $10M
Inhibitor Therapeutics, Inc.
BEARISH -53
ORGS —
Orgenesis Inc.
BEARISH -53
AFFY —
Affymax, Inc.
BEARISH -53
PLYX $90M
Polaryx Therapeutics, Inc. Common Stock
BEARISH -55
VBIZF $400M
Viva Biotech Holdings
BEARISH -56
SPRB $130M
Spruce Biosciences, Inc.
BEARISH -56
OKUR $100M
OnKure Therapeutics, Inc.
BEARISH -56
SYRS —
Syros Pharmaceuticals, Inc.
BEARISH -56
IMTX $1.1B
Immatics N.V.
BEARISH -58
AVBP $1.0B
ArriVent BioPharma, Inc.
BEARISH -58
ZURA $320M
Zura Bio Limited
BEARISH -58
CLVLF $250M
Clinuvel Pharmaceuticals Limited
BEARISH -58
BCYC $250M
Bicycle Therapeutics plc
BEARISH -58
CDXS $140M
Codexis, Inc.
BEARISH -58
RNXT $60M
RenovoRx, Inc.
BEARISH -58
SGMOQ $50M
Sangamo Therapeutics, Inc.
BEARISH -58
SEOVF $30M
Sernova Corp.
BEARISH -58
SNANF $20M
Sona Nanotech Inc.
BEARISH -58
RVXCF $20M
Resverlogix Corp.
BEARISH -58
HMTXF $10M
Hemostemix Inc.
BEARISH -58
AMBS —
Amarantus BioScience Holdings, Inc.
BEARISH -58
ANTH —
Anthera Pharmaceuticals, Inc.
BEARISH -58
BRTX —
BioRestorative Therapies, Inc.
BEARISH -58
ATRX —
Adhera Therapeutics Inc
BEARISH -58
AMPE —
Ampio Pharmaceuticals, Inc.
BEARISH -58
LIPO —
Lipella Pharmaceuticals Inc.
BEARISH -58
CVKD —
Cadrenal Therapeutics, Inc. Common Stock
BEARISH -58
MAJI —
Nextel Medical Corp.
BEARISH -58
AURA $650M
Aura Biosciences, Inc.
BEARISH -59
ARCT $280M
Arcturus Therapeutics Holdings Inc.
BEARISH -59
ATRA $90M
Atara Biotherapeutics, Inc.
BEARISH -59
IMRN $10M
Immuron Limited
BEARISH -59
SKYE $10M
Skye Bioscience, Inc.
BEARISH -59
ERNAW —
Ernexa Therapeutics Inc. Warrants
BEARISH -59
CUBT —
Curative Biotechnology, Inc.
BEARISH -59
IDRSF $1.4B
Idorsia Ltd
BEARISH -60
QTTB $260M
Q32 Bio Inc.
BEARISH -60
BRIBF $90M
Brii Biosciences Limited
BEARISH -60
AUTL $410M
Autolus Therapeutics plc
BEARISH -62
BVAXF —
BioVaxys Technology Corp.
BEARISH -62
TELO $70M
Telomir Pharmaceuticals, Inc. Common Stock
BEARISH -65
RECEF $70M
Recce Pharmaceuticals Ltd
BEARISH -65
CVM $30M
CEL-SCI Corporation
BEARISH -65
SNGX $10M
Soligenix, Inc.
BEARISH -65
ARTL $10M
Artelo Biosciences, Inc.
BEARISH -65
LIFS —
Life Stem Genetics Inc.
BEARISH -65
FNAM —
Evolutionary Genomics, Inc.
BEARISH -65
WINT —
Windtree Therapeutics, Inc.
BEARISH -65
RGRX —
RegeneRx Biopharmaceuticals, Inc.
BEARISH -65
SYBE —
SYBLEU Inc
BEARISH -65
BICTF —
Biocure Technology Inc.
BEARISH -65
VOR $990M
Vor Biopharma Inc.
BEARISH -66
ASCLF $770M
Ascletis Pharma Inc.
BEARISH -66
YDES $350M
YD Bio Limited Ordinary Shares
BEARISH -66
CAMP $210M
CAMP4 Therapeutics Corporation
BEARISH -66
RNAC $190M
Cartesian Therapeutics, Inc.
BEARISH -66
VRXA $140M
Veraxa Biotech Holding AG
BEARISH -66
OTLK $130M
Outlook Therapeutics, Inc.
BEARISH -66
ONCY $50M
Oncolytics Biotech Inc.
BEARISH -66
CNTB $50M
Connect Biopharma Holdings Limited
BEARISH -66
ALPS $50M
Alps Group Inc
BEARISH -66
CLCS $40M
Cell Source, Inc.
BEARISH -66
BYSI $20M
BeyondSpring Inc.
BEARISH -66
CNTX $20M
Context Therapeutics Inc.
BEARISH -66
PLRZ $10M
Polyrizon Ltd.
BEARISH -66
ADIL $10M
Adial Pharmaceuticals, Inc.
BEARISH -66
LPCN $10M
Lipocine Inc.
BEARISH -66
GLWLF $10M
Glow Lifetech Corp.
BEARISH -66
KTTA $10M
Pasithea Therapeutics Corp.
BEARISH -66
ICU $10M
SeaStar Medical Holding Corporation
BEARISH -66
ONCO —
Onconetix, Inc.
BEARISH -66
BBLG —
Bone Biologics Corporation
BEARISH -66
AFMDQ —
Affimed N.V.
BEARISH -66
EVLO —
Evelo Biosciences, Inc.
BEARISH -66
VCNX —
Vaccinex, Inc.
BEARISH -66
VIVS —
VivoSim Labs, Inc.
BEARISH -66
SXTP —
60 Degrees Pharmaceuticals, Inc.
BEARISH -66
SPRC —
SciSparc Ltd.
BEARISH -66
MTNB —
Matinas BioPharma Holdings, Inc.
BEARISH -66
NCEL —
NewcelX Ltd.
BEARISH -66
DRMA —
Dermata Therapeutics, Inc.
BEARISH -66
ITMC —
Itoco Inc.
BEARISH -66
OBIO $340M
Orchestra BioMed Holdings, Inc.
BEARISH -68
ACOG $130M
Alpha Cognition Inc
BEARISH -68
LITS $40M
Lite Strategy, Inc.
BEARISH -68
NXTC $20M
NextCure, Inc.
BEARISH -68
BCTXZ —
BriaCell Therapeutics Corp. Warrant
BEARISH -68
TRVI $1.8B
Trevi Therapeutics, Inc.
BEARISH -69
QURE $1.6B
uniQure N.V.
BEARISH -69
MGTX $880M
MeiraGTx Holdings plc
BEARISH -69
ABUS $830M
Arbutus Biopharma Corp
BEARISH -69
AMGXF $140M
AnGes, Inc.
BEARISH -69
BBIXF $50M
Bonus BioGroup Ltd.
BEARISH -69
XTLB —
XTL Biopharmaceuticals Ltd.
BEARISH -69
MYMX —
Mymetics Corporation
BEARISH -69
NWPHF $410M
Newron Pharmaceuticals S.p.A.
BEARISH -71
SRNE —
Sorrento Therapeutics, Inc.
BEARISH -73
PBLA —
Panbela Therapeutics, Inc.
BEARISH -73
CPMV —
Mosaic ImmunoEngineering Inc.
BEARISH -73
MNKD $1.0B
MannKind Corporation
BEARISH -74
APMD $790M
Apnimed, Inc.
BEARISH -74
SABS $260M
SAB Biotherapeutics, Inc.
BEARISH -74
IMRX $240M
Immuneering Corporation
BEARISH -74
HUMA $120M
Humacyte, Inc.
BEARISH -74
BTAIQ —
BioXcel Therapeutics, Inc.
BEARISH -74
TSOI —
Therapeutic Solutions International, Inc.
BEARISH -74
BCRX $1.9B
BioCryst Pharmaceuticals, Inc.
BEARISH -75
GENB $1.6B
Generate Biomedicines, Inc.
BEARISH -75
CMPS $1.6B
COMPASS Pathways plc
BEARISH -75
INBX $1.4B
Inhibrx Biosciences Inc.
BEARISH -75
OMER $1.2B
Omeros Corporation
BEARISH -75
ACHV $670M
Achieve Life Sciences, Inc.
BEARISH -75
NVCT $650M
Nuvectis Pharma, Inc.
BEARISH -75
MDXG $570M
MiMedx Group, Inc.
BEARISH -75
STTK $550M
Shattuck Labs, Inc.
BEARISH -75
CBIO $480M
Crescent Biopharma, Inc.
BEARISH -75
RZLT $370M
Rezolute, Inc.
BEARISH -75
FENC $350M
Fennec Pharmaceuticals Inc.
BEARISH -75
DMTRF $310M
3-D Matrix, Ltd.
BEARISH -75
CUE $140M
Cue Biopharma, Inc.
BEARISH -75
VANI $100M
Vivani Medical, Inc.
BEARISH -75
MNOV $70M
MediciNova, Inc.
BEARISH -75
NDTP $50M
NDT Pharmaceuticals Inc.
BEARISH -75
CRVO $30M
CervoMed Inc.
BEARISH -75
CELU $30M
Celularity Inc.
BEARISH -75
TELIF $20M
Telescope Innovations Corp.
BEARISH -75
COCP $20M
Cocrystal Pharma, Inc.
BEARISH -75
PVCT $20M
Provectus Biopharmaceuticals, Inc.
BEARISH -75
LTRN $10M
Lantern Pharma Inc.
BEARISH -75
PHYOF $10M
IXICO plc
BEARISH -75
PASG $10M
Passage Bio, Inc.
BEARISH -75
CDT —
CDT Equity Inc.
BEARISH -75
ADTX —
Aditxt, Inc.
BEARISH -75
YDESW —
YD Bio Limited Warrants
BEARISH -75
HMGN —
Hemagen Diagnostics, Inc.
BEARISH -75
YECO —
EV Biologics, Inc.
BEARISH -75
LIMNW —
Liminatus Pharma, Inc. Warrants
BEARISH -75
AXIM —
AXIM Biotechnologies, Inc.
BEARISH -75
RGBPP —
Regen BioPharma, Inc.
BEARISH -75
CHMMF —
Chimeric Therapeutics Limited
BEARISH -75
BLEG —
Branded Legacy, Inc.
BEARISH -75
GRI —
GRI Bio, Inc.
BEARISH -75
NMLSF —
Restart Life Sciences Corp.
BEARISH -75
AGNPF —
Grey Matters Health Inc.
BEARISH -75
LNAI —
Lunai Bioworks Inc.
BEARISH -75
GHRS $1.2B
GH Research PLC
BEARISH -78
ANRO $860M
Alto Neuroscience, Inc.
BEARISH -78
AKTS $850M
Aktis Oncology, Inc.
BEARISH -78
DSGN $640M
Design Therapeutics, Inc.
BEARISH -78
SLDB $630M
Solid Biosciences Inc.
BEARISH -78
LXRX $630M
Lexicon Pharmaceuticals, Inc.
BEARISH -78
ANL $560M
Adlai Nortye Ltd.
BEARISH -78
MNPR $470M
Monopar Therapeutics Inc.
BEARISH -78
AVIR $320M
Atea Pharmaceuticals, Inc.
BEARISH -78
ARTV $300M
Artiva Biotherapeutics, Inc.
BEARISH -78
WHWK $180M
Whitehawk Therapeutics Inc
BEARISH -78
ANTX $130M
AN2 Therapeutics, Inc.
BEARISH -78
NRXP $110M
NRx Pharmaceuticals, Inc.
BEARISH -78
ELOX $40M
Eloxx Pharmaceuticals, Inc.
BEARISH -78
BMEA $40M
Biomea Fusion, Inc.
BEARISH -78
TVGN $30M
Tevogen Bio Holdings Inc.
BEARISH -78
AVEFF $20M
Avecho Biotechnology Limited
BEARISH -78
CMMB $10M
Chemomab Therapeutics Ltd.
BEARISH -78
KZIA $10M
Kazia Therapeutics Ltd ADR
BEARISH -78
SYBX $10M
Synlogic, Inc.
BEARISH -78
XRTX —
XORTX Therapeutics Inc.
BEARISH -78
HXBM —
Helix BioMedix, Inc.
BEARISH -78
OZYMF —
Strategic Partners A/S
BEARISH -78
GNLKQ —
GeneLink, Inc.
BEARISH -78
RMTG —
Regenerative Medical Technology Group Inc.
BEARISH -78
GLABF —
Gemina Laboratories Ltd.
BEARISH -78
HBMHF $1.3B
HBM Holdings Limited
BEARISH -82
BCAX $1.1B
Bicara Therapeutics Inc. Common Stock
BEARISH -82
NKTR $1.1B
Nektar Therapeutics
BEARISH -82
GLUE $920M
Monte Rosa Therapeutics, Inc.
BEARISH -82
ALMS $880M
Alumis Inc.
BEARISH -82
AGMB $450M
AgomAb Therapeutics N.V. American Depositary Shares
BEARISH -82
BLSM $430M
BlossomHill Therapeutics, Inc.
BEARISH -82
EIKN $390M
Eikon Therapeutics, Inc. Common Stock
BEARISH -82
RLMD $350M
Relmada Therapeutics, Inc.
BEARISH -82
BNTC $300M
Benitec Biopharma Inc.
BEARISH -82
IPSC $260M
Century Therapeutics, Inc.
BEARISH -82
RCKT $250M
Rocket Pharmaceuticals, Inc.
BEARISH -82
BOVNF $220M
BioInvent International AB (publ)
BEARISH -82
CHRS $160M
Coherus Oncology, Inc.
BEARISH -82
VXRT $100M
Vaxart, Inc.
BEARISH -82
IMUX $100M
Immunic, Inc.
BEARISH -82
ADAG $90M
Adagene Inc.
BEARISH -82
NMRA $70M
Neumora Therapeutics, Inc. Common Stock
BEARISH -82
TENX $50M
Tenax Therapeutics, Inc.
BEARISH -82
IMA $50M
ImageneBio Inc
BEARISH -82
IBO $30M
Impact BioMedical Inc.
BEARISH -82
NEUP $20M
Neuphoria Therapeutics Inc.
BEARISH -82
PRRUF $20M
Immutep Limited
BEARISH -82
CLRB $10M
Cellectar Biosciences, Inc.
BEARISH -82
AIM $10M
AIM ImmunoTech Inc.
BEARISH -82
CTXR $10M
Citius Pharmaceuticals, Inc.
BEARISH -82
RADX —
Radiopharm Theranostics Limited
BEARISH -82
LGVN —
Longeveron Inc.
BEARISH -82
APVO —
Aptevo Therapeutics Inc.
BEARISH -82
ARNI —
Arno Therapeutics, Inc.
BEARISH -82
MYNDF —
MYND Life Sciences Inc.
BEARISH -82
SEPSF —
Asep Medical Holdings Inc
BEARISH -82
BIOAF —
Bioasis Technologies Inc.
BEARISH -82
ARUXF —
Acrux Limited
BEARISH -82
ORIC $1.4B
ORIC Pharmaceuticals, Inc.
BEARISH -84
KURA $850M
Kura Oncology, Inc.
BEARISH -84
FDMT $600M
4D Molecular Therapeutics, Inc.
BEARISH -84
ZVRA $580M
Zevra Therapeutics, Inc.
BEARISH -84
EPRX $450M
Eupraxia Pharmaceuticals Inc.
BEARISH -84
AGEN $290M
Agenus Inc.
BEARISH -84
IRD $290M
Opus Genetics, Inc.
BEARISH -84
GALT $210M
Galectin Therapeutics Inc.
BEARISH -84
CGEN $180M
Compugen Ltd.
BEARISH -84
MGNX $140M
MacroGenics, Inc.
BEARISH -84
SEER $110M
Seer, Inc.
BEARISH -84
COYA $90M
Coya Therapeutics, Inc.
BEARISH -84
ACRV $70M
Acrivon Therapeutics, Inc. Common Stock
BEARISH -84
PMVP $70M
PMV Pharmaceuticals, Inc.
BEARISH -84
HRTX $60M
Heron Therapeutics, Inc.
BEARISH -84
OSTX $60M
OS Therapies Incorporated
BEARISH -84
SPRO $60M
Spero Therapeutics, Inc.
BEARISH -84
XLO $50M
Xilio Therapeutics, Inc.
BEARISH -84
AKTX $20M
Akari Therapeutics, Plc
BEARISH -84
KPRX $10M
Kiora Pharmaceuticals, Inc.
BEARISH -84
OTLC $10M
Oncotelic Therapeutics, Inc.
BEARISH -84
ENVB $10M
Enveric Biosciences, Inc.
BEARISH -84
PTIX —
Protagenic Therapeutics, Inc.
BEARISH -84
ISCO —
International Stem Cell Corporation
BEARISH -84
PBM —
Psyence Biomedical Ltd.
BEARISH -84
RVLPQ —
RVL Pharmaceuticals plc
BEARISH -84
URGN $1.7B
UroGen Pharma Ltd.
BEARISH -87
NVAX $1.6B
Novavax, Inc.
BEARISH -87
NUVB $1.6B
Nuvation Bio Inc.
BEARISH -87
DRTS $1.2B
Alpha Tau Medical Ltd
BEARISH -87
MDCLF $1.1B
MedinCell S.A.
BEARISH -87
IMMX $680M
Immix Biopharma, Inc.
BEARISH -87
CADL $610M
Candel Therapeutics, Inc.
BEARISH -87
CLYM $590M
Climb Bio, Inc.
BEARISH -87
GNFTF $470M
Genfit S.A.
BEARISH -87
AVCTF $420M
Avacta Group Plc
BEARISH -87
IKT $220M
Inhibikase Therapeutics, Inc.
BEARISH -87
PLX $210M
Protalix BioTherapeutics, Inc.
BEARISH -87
PRQR $180M
ProQR Therapeutics N.V.
BEARISH -87
ORMP $170M
Oramed Pharmaceuticals Inc.
BEARISH -87
TRGNF $120M
Transgene S.A.
BEARISH -87
PYXS $110M
Pyxis Oncology, Inc.
BEARISH -87
PRNAF $50M
Alterity Therapeutics Limited
BEARISH -87
BOLD $50M
Boundless Bio, Inc.
BEARISH -87
BMNDF $20M
Biomind Labs Inc.
BEARISH -87
SER $20M
Serina Therapeutics, Inc.
BEARISH -87
ALZN $10M
Alzamend Neuro Inc
BEARISH -87
XBIO —
Xenetic Biosciences, Inc.
BEARISH -87
SNDX $1.2B
Syndax Pharmaceuticals, Inc.
BEARISH -91
ARDX $770M
Ardelyx, Inc.
BEARISH -91
GERN $720M
Geron Corporation
BEARISH -91
SANA $700M
Sana Biotechnology, Inc.
BEARISH -91
SLBT $640M
SL Science Holding Ltd
BEARISH -91
WVE $630M
Wave Life Sciences Ltd.
BEARISH -91
GYRE $620M
Gyre Therapeutics, Inc.
BEARISH -91
ANNX $610M
Annexon, Inc.
BEARISH -91
OLMA $560M
Olema Pharmaceuticals, Inc.
BEARISH -91
CTMX $510M
CytomX Therapeutics, Inc.
BEARISH -91
SPRY $400M
ARS Pharmaceuticals, Inc.
BEARISH -91
MPLT $340M
MapLight Therapeutics, Inc.
BEARISH -91
SPHDF $280M
Santhera Pharmaceuticals Holding AG
BEARISH -91
VOGX $260M
Vogenx Inc.
BEARISH -91
ORYZF $250M
Oryzon Genomics S.A.
BEARISH -91
VNDA $240M
Vanda Pharmaceuticals Inc.
BEARISH -91
LRMR $240M
Larimar Therapeutics, Inc.
BEARISH -91
HLOSF $240M
Healios K.K.
BEARISH -91
LXEO $230M
Lexeo Therapeutics, Inc. Common Stock
BEARISH -91
IPHYF $210M
Innate Pharma S.A.
BEARISH -91
BBOT $210M
BridgeBio Oncology Therapeutics Inc.
BEARISH -91
ELDN $190M
Eledon Pharmaceuticals, Inc.
BEARISH -91
BIOA $190M
BioAge Labs Inc.
BEARISH -91
EVMN $190M
Evommune, Inc.
BEARISH -91
AKBA $160M
Akebia Therapeutics, Inc.
BEARISH -91
ZNTL $160M
Zentalis Pharmaceuticals, Inc.
BEARISH -91
NBP $160M
NovaBridge Biosciences
BEARISH -91
NGEN $150M
NervGen Pharma Corp. Common stock
BEARISH -91
MDWD $150M
MediWound Ltd.
BEARISH -91
TARA $140M
Protara Therapeutics, Inc.
BEARISH -91
NKTX $130M
Nkarta, Inc.
BEARISH -91
MENS $130M
Jyong Biotech Ltd. Ordinary Shares
BEARISH -91
AVXL $120M
Anavex Life Sciences Corp.
BEARISH -91
UNCY $110M
Unicycive Therapeutics, Inc.
BEARISH -91
CBUS $110M
Cibus, Inc.
BEARISH -91
LENZ $100M
LENZ Therapeutics, Inc.
BEARISH -91
ORPOF $100M
OSE Immunotherapeutics S.A.
BEARISH -91
TNYA $90M
Tenaya Therapeutics, Inc.
BEARISH -91
TNXP $90M
Tonix Pharmaceuticals Holding Corp.
BEARISH -91
CNXU $90M
Conexeu Sciences Inc.
BEARISH -91
CRBP $80M
Corbus Pharmaceuticals Holdings, Inc.
BEARISH -91
MIST $80M
Milestone Pharmaceuticals Inc.
BEARISH -91
JWCTF $80M
JW (Cayman) Therapeutics Co. Ltd
BEARISH -91
PMN $70M
ProMIS Neurosciences, Inc.
BEARISH -91
MAIA $70M
MAIA Biotechnology, Inc.
BEARISH -91
CGTX $70M
Cognition Therapeutics, Inc.
BEARISH -91
CRBU $60M
Caribou Biosciences, Inc.
BEARISH -91
TLSA $60M
Tiziana Life Sciences Ltd
BEARISH -91
GOSS $60M
Gossamer Bio, Inc.
BEARISH -91
HBPCF $60M
Helix BioPharma Corp.
BEARISH -91
INO $60M
Inovio Pharmaceuticals, Inc.
BEARISH -91
VTIAF $50M
FamiCord AG
BEARISH -91
PLRX $50M
Pliant Therapeutics, Inc.
BEARISH -91
GANX $50M
Gain Therapeutics, Inc.
BEARISH -91
HYFT $50M
MindWalk Holdings Corp.
BEARISH -91
DWTX $40M
Dogwood Therapeutics, Inc.
BEARISH -91
ALDX $40M
Aldeyra The
BEARISH -91
RANI $40M
Rani Therapeutics Holdings, Inc.
BEARISH -91
IGC $30M
IGC Pharma, Inc.
BEARISH -91
FLNA $30M
Filana Therapeutics, Inc.
BEARISH -91
IXHL $30M
Incannex Healthcare Limited
BEARISH -91
MCRB $20M
Seres Therapeutics, Inc.
BEARISH -91
ATYR $20M
aTyr Pharma, Inc.
BEARISH -91
TCRX $10M
TScan Therapeutics, Inc.
BEARISH -91
RDTCF $10M
Rapid Dose Therapeutics Corp.
BEARISH -91
GUTS $10M
Fractyl Health, Inc.
BEARISH -91
TPST $10M
Tempest Therapeutics, Inc.
BEARISH -91
HIND $10M
Vyome Holdings, Inc.
BEARISH -91
ACTU $10M
Actuate Therapeutics Inc
BEARISH -91
QNRX $10M
Quoin Pharmaceuticals, Ltd.
BEARISH -91
NCNA $10M
NuCana plc
BEARISH -91
GSGTF $10M
GenSight Biologics S.A.
BEARISH -91
INTS $10M
Intensity Therapeutics, Inc.
BEARISH -91
PXXLF $10M
Poxel S.A.
BEARISH -91
TOVX $10M
Theriva Biologics, Inc.
BEARISH -91
QNTM $10M
Quantum BioPharma Ltd.
BEARISH -91
CDIO $10M
Cardio Diagnostics Holdings, Inc.
BEARISH -91
VTGN $10M
VistaGen Therapeutics, Inc.
BEARISH -91
OPTBF $10M
OptiBiotix Health Plc
BEARISH -91
DARE $10M
Dare Bioscience, Inc.
BEARISH -91
RASP —
Actavia Life Sciences, Inc.
BEARISH -91
LIMN —
Liminatus Pharma, Inc. Class A Common Stock
BEARISH -91
NAVBQ —
Navidea Biopharmaceuticals, Inc.
BEARISH -91
SUVZ —
Suvanza Pharma, LLC
BEARISH -91
HCWB —
HCW Biologics Inc.
BEARISH -91
KAPA —
Kairos Pharma, Ltd.
BEARISH -91
GOVX —
GeoVax Labs, Inc.
BEARISH -91
VBIO —
Valion Bio, Inc.
BEARISH -91
TNGNQ —
Tengion, Inc.
BEARISH -91
CELZ —
Creative Medical Technology Holdings, Inc.
BEARISH -91
ENDV —
Endonovo Therapeutics, Inc.
BEARISH -91
VPRO —
Viropro Inc.
BEARISH -91
ZVSA —
ZyVersa Therapeutics, Inc.
BEARISH -91
EVFM —
Evofem Biosciences, Inc.
BEARISH -91
NBRVF —
Nabriva Therapeutics plc
BEARISH -91
KALA —
KALA BIO, Inc.
BEARISH -91
WSNAF —
Wesana Health Holdings Inc.
BEARISH -91
BNIGF —
Beroni Group Limited
BEARISH -91
SILO —
Silo Pharma, Inc.
BEARISH -91
ENLV —
Enlivex Therapeutics Ltd.
BEARISH -91
EVGN —
Evogene Ltd.
BEARISH -91
XENO —
Xeno Transplants Corporation
BEARISH -91
ZHCLF —
Zenith Capital Corp.
BEARISH -91
PMCB —
PharmaCyte Biotech, Inc.
BEARISH -91
MLECW —
Moolec Science S.A.
BEARISH -91
GENSF $1.8B
Genus plc
BEARISH -100
MLYS $1.8B
Mineralys Therapeutics, Inc.
BEARISH -100
OCUL $1.4B
Ocular Therapeutix, Inc.
BEARISH -100
GPCR $1.2B
Structure Therapeutics Inc.
BEARISH -100
SVRA $870M
Savara Inc.
BEARISH -100
IVEVF $750M
Inventiva S.A.
BEARISH -100
ATTO $630M
Attovia Therapeutics, Inc.
BEARISH -100
PROK $470M
ProKidney Corp.
BEARISH -100
PHAT $460M
Phathom Pharmaceuticals, Inc.
BEARISH -100
FTH $440M
Faeth Therapeutics, Inc.
BEARISH -100
RGNX $440M
REGENXBIO Inc.
BEARISH -100
ALLO $430M
Allogene Therapeutics, Inc.
BEARISH -100
ALT $410M
Altimmune, Inc.
BEARISH -100
ASMB $400M
Assembly Biosciences, Inc.
BEARISH -100
TECX $390M
Tectonic Therapeutic, Inc.
BEARISH -100
AVTX $370M
Avalo Therapeutics, Inc.
BEARISH -100
CAPR $340M
Capricor Therapeutics, Inc.
BEARISH -100
KYTX $330M
Kyverna Therapeutics, Inc.
BEARISH -100
FULC $280M
Fulcrum Therapeutics, Inc.
BEARISH -100
CTNM $270M
Contineum Therapeutics, Inc.
BEARISH -100
ACIU $250M
AC Immune S.A.
BEARISH -100
ABEO $250M
Abeona Therapeutics Inc.
BEARISH -100
CABA $250M
Cabaletta Bio, Inc.
BEARISH -100
SCTX $250M
Scribe Therapeutics Inc.
BEARISH -100
OCGN $250M
Ocugen, Inc.
BEARISH -100
PALI $230M
Palisade Bio, Inc.
BEARISH -100
NAGE $190M
Niagen Bioscience Inc
BEARISH -100
IVVD $180M
Invivyd, Inc.
BEARISH -100
SION $160M
Sionna Therapeutics, Inc.
BEARISH -100
UPB $150M
Upstream Bio, Inc.
BEARISH -100
STRO $150M
Sutro Biopharma, Inc.
BEARISH -100
CNTN $150M
Canton Strategic Holdings Inc
BEARISH -100
CMPX $140M
Compass Therapeutics, Inc.
BEARISH -100
VYGR $110M
Voyager Therapeutics, Inc.
BEARISH -100
NERV $110M
Minerva Neurosciences, Inc.
BEARISH -100
VTVT $100M
vTv Therapeutics Inc.
BEARISH -100
CLLS $100M
Cellectis S.A.
BEARISH -100
ENGN $100M
enGene Holdings Inc.
BEARISH -100
GNLX $90M
Genelux Corporation
BEARISH -100
CRDF $70M
Cardiff Oncology, Inc.
BEARISH -100
PTHS $70M
Pelthos Therapeutics Inc.
BEARISH -100
VRCA $60M
Verrica Pharmaceuticals Inc.
BEARISH -100
XBIT $60M
XBiotech Inc.
BEARISH -100
IBIO $50M
iBio, Inc.
BEARISH -100
RNTX $50M
Rein Therapeutics Inc.
BEARISH -100
EXOZ $40M
eXoZymes, Inc.
BEARISH -100
VERU $40M
Veru Inc.
BEARISH -100
ANVS $40M
Annovis Bio, Inc.
BEARISH -100
KLRS $40M
Kalaris Therapeutics Inc
BEARISH -100
ACET $40M
Adicet Bio, Inc.
BEARISH -100
TIL $40M
Instil Bio, Inc.
BEARISH -100
MREO $40M
Mereo BioPharma Group plc
BEARISH -100
ALGS $30M
Aligos Therapeutics, Inc.
BEARISH -100
EDSA $30M
Edesa Biotech, Inc.
BEARISH -100
AARD $30M
Aardvark Therapeutics, Inc. Common Stock
BEARISH -100
BSEM $30M
BioStem Technologies, Inc.
BEARISH -100
NRXBF $30M
NurExone Biologic Inc.
BEARISH -100
EYPT $30M
EyePoint Pharmaceuticals, Inc.
BEARISH -100
BCTX $30M
BriaCell Therapeutics Corp.
BEARISH -100
MGX $30M
Metagenomi, Inc. Common Stock
BEARISH -100
GRCE $30M
Grace Therapeutics, Inc.
BEARISH -100
BXPHF $20M
Botanix Pharmaceuticals Limited
BEARISH -100
KYNB $20M
Kyntra Bio, Inc.
BEARISH -100
MVMDF $20M
More Life Company Corp.
BEARISH -100
MSLE $10M
Satellos Bioscience Inc.
BEARISH -100
FBLG $10M
FibroBiologics, Inc. Common Stock
BEARISH -100
INAB $10M
IN8bio, Inc.
BEARISH -100
APRE $10M
Aprea Therapeutics, Inc.
BEARISH -100
PTN $10M
Palatin Technologies, Inc.
BEARISH -100
AIMD $10M
Ainos, Inc.
BEARISH -100
TRAW $10M
Traws Pharma, Inc.
BEARISH -100
BCDA $10M
BioCardia, Inc.
BEARISH -100
ACXP $10M
Acurx Pharmaceuticals, Inc.
BEARISH -100
BLRX $10M
BioLineRx Ltd.
BEARISH -100
MTVA $10M
MetaVia Inc.
BEARISH -100
TVRD $10M
Tvardi Therapeutics, Inc.
BEARISH -100
GTBP $10M
GT Biopharma, Inc.
BEARISH -100
PHIO $10M
Phio Pharmaceuticals Corp.
BEARISH -100
RVPH $10M
Reviva Pharmaceuticals Holdings, Inc.
BEARISH -100
CODX —
Co-Diagnostics, Inc.
BEARISH -100
FAMDF —
Futura Medical plc
BEARISH -100
PPBT —
Purple Biotech Ltd.
BEARISH -100
GNPX —
Genprex, Inc.
BEARISH -100
OGEN —
Oragenics, Inc.
BEARISH -100
LABT —
Lakewood-Amedex Biotherapeutics, Inc.
BEARISH -100
MBAI —
MBody AI Ltd.
BEARISH -100
DCOY —
Decoy Therapeutics Inc.
BEARISH -100
NSHSF —
NanoSphere Health Sciences Inc.
BEARISH -100
ELAB —
PMGC Holdings Inc.
BEARISH -100
VRXAW —
Veraxa Biotech AG
BEARISH -100
CLDI —
Calidi Biotherapeutics, Inc.
BEARISH -100
MBIO —
Mustang Bio, Inc.
BEARISH -100
SCPX —
Scorpius Holdings, Inc.
BEARISH -100
MDCX —
Medicus Pharma Ltd. Common Stock
BEARISH -100
NRSN —
NeuroSense Therapeutics Ltd.
BEARISH -100
ZLDAF —
Zelira Therapeutics Limited
BEARISH -100
CANF —
Can-Fite BioPharma Ltd.
BEARISH -100
CRIS —
Curis, Inc.
BEARISH -100
NIKI —
Niki BioSolutions, Inc.
BEARISH -100
OXBOF —
Oxford BioDynamics Plc
BEARISH -100
XSNX —
NovAccess Global Inc.
BEARISH -100

Peer Comparison

Symbol Mkt Cap P/E ROE % ROIC % Net Mgn % Rev Grw % Piotroski Signal 1Y Ret %
INMB INmune Bio, Inc. $40M -2.2 -74.8 -475.4 — -100.0 2 BEARISH -20.1
SGP SpyGlass Pharma, Inc. Common Stock $950M — — — — — — BULLISH —
VSTM Verastem, Inc. $910M -4.1 -471.2 6197.3 -86.5 3995.7 4 BULLISH 28.0
SOLTF Nxera Pharma Co., Ltd. $770M -15.8 -12.0 -1.7 -2.6 7.5 4 BULLISH 41.9
GRDX GridAI Technologies Corp. $40M -1.4 -55.6 -51.7 -14927.4 67.4 2 BULLISH 27.3
ENTX Entera Bio Ltd. $510M -8.8 -138.9 314.4 — -100.0 1 BULLISH 33.6
ATNM Actinium Pharmaceuticals, Inc. $50M 4.0 45.9 -197.8 79.7 — 3 BULLISH -2.1
XFOR X4 Pharmaceuticals, Inc. $320M -2.7 -113.1 -281.1 -183.5 -51.6 4 BULLISH 5.2
ESLA Estrella Immunopharma, Inc. $40M -3.8 148.1 102.1 — — 3 BULLISH -60.6
KRRO Korro Bio, Inc. $180M -1.3 -97.7 -196.6 — -62.1 2 BULLISH -68.0
HURA TuHURA Biosciences, Inc. $140M -3.8 -161.4 -137.6 — — 2 BULLISH -8.5
ZIVO ZIVO Bioscience, Inc. $20M -4.5 185.9 147.5 — -62.5 2 BULLISH -53.1
RIGL Rigel Pharmaceuticals, Inc. $900M 2.8 126.9 88.5 22.0 3.3 4 BULLISH 69.9
CING Cingulate Inc. $70M -1.1 -198.7 -1452.8 — — 4 BULLISH 44.7
AGTX Agentix Corp. — -5.1 12.0 8.1 — — 3 BULLISH 6.9
ACUT Accustem Sciences Inc. — -1.4 49.7 34.0 -256.7 2610.7 4 BULLISH -87.3
XNCR Xencor, Inc. $1.9B -13.7 -29.1 -152.4 -42.4 -36.1 2 BULLISH 136.5
KLRA Kailera Therapeutics, Inc. $1.7B — — — — — — BULLISH —
TRAX First Tracks Biotherapeutics Inc $1.6B — — — — — — BULLISH —
LBRX LB Pharmaceuticals Inc Common Stock $1.2B -13.4 -25.8 -768.9 — — 2 BULLISH 148.4
SLN Silence Therapeutics plc $930M -5.2 -90.4 157.8 — -97.6 1 BULLISH 172.8
PBYI Puma Biotechnology, Inc. $570M 20.3 22.0 52.8 14.5 -2.9 6 BULLISH 115.3
MXCT MaxCyte, Inc. $140M -4.7 -20.4 -38.9 -122.0 -13.2 2 BULLISH -6.8
IRLA IRulya Therapeutics Inc. $30M — — — — — — BULLISH —
MBXBF Microbix Biosystems Inc. $30M -8.6 -16.4 -14.6 -19.9 -27.1 3 BULLISH 29.9
BOLT Bolt Biotherapeutics, Inc. $10M -0.4 -111.6 -138.8 -154400.0 12.8 3 BULLISH 14.4
AZTR Azitra, Inc. — -0.1 -256.7 -959.6 — — 5 BULLISH 118.9
BDRX Biodexa Pharmaceuticals Plc — -0.1 -42.3 -117.9 — — 2 BULLISH -89.2
CBDG THC Farmaceuticals, Inc. — -30.9 2.0 -0.9 — 28.1 5 BULLISH -60.2
PHAR Pharming Group N.V. $710M 81.8 3.6 3.2 1.8 7.8 7 BULLISH -19.6
INDP Indaptus Therapeutics, Inc. $360M -0.5 -318.0 6437.4 — — 4 BULLISH -5.9
ANIX Anixa Biosciences, Inc. $100M -10.7 -67.1 -1110.2 — — 3 BULLISH -29.9
NRXS NeurAxis, Inc. $90M -9.6 -143.2 464.1 -118.1 65.2 6 BULLISH 89.8
OABIW OmniAb, Inc. $1.1B -13.8 -16.9 -16.8 -43.7 66.9 6 BULLISH -42.2
DMAC DiaMedica Therapeutics Inc. $470M -11.9 -114.6 616.3 — — 2 BULLISH 29.3
SCNLF Scancell Holdings plc $170M -5.1 153.2 179.2 — -100.0 2 BULLISH 969.8
ICCC ImmuCell Corporation $90M 124.9 2.6 10.2 25.5 8.5 6 BULLISH 69.0
SPTX Seaport Therapeutics, Inc. Common Stock $1.1B — — — — — — BULLISH —
CASBF CanSino Biologics Inc. $1.4B 367.7 0.8 -1.2 11.0 32.5 7 BULLISH -25.5
BRVE Braveheart Bio, Inc. $1.5B — — — — — — BULLISH —
TXTM ProText Mobility, Inc. $90M 90.0 -0.4 -0.3 — -100.0 1 BULLISH 377.3
IMNN Imunon, Inc. $10M -0.2 -429.7 -226.7 — — 2 BULLISH -75.0
HALB Halberd Corporation — -25.4 11.6 12.4 — -52.1 1 BULLISH -13.9
SEPN Septerna Inc $1.9B -81.5 -6.3 -93.1 -48.7 17878.5 5 BULLISH 89.9
MAZE Maze Therapeutics, Inc. $1.7B -11.4 -37.3 -112.3 — — 3 BULLISH 3.9
COAG Hemab Therapeutics Holdings, Inc. Common Stock $1.6B — — — — — — BULLISH —
CRMD CorMedix Inc. $610M 3.3 54.9 57.2 25.5 280.5 5 BULLISH -29.8
PYPD PolyPid Ltd. $110M -3.9 -1913.8 231.6 — — 3 BULLISH 53.8
ADCT ADC Therapeutics S.A. $180M -2.4 45.3 260.9 -86.1 2.0 2 BULLISH -62.9
NYMXF Nymox Pharmaceutical Corporation $10M -0.9 193.9 89.4 — — 2 BULLISH -62.8
PRME Prime Medicine, Inc. $670M -4.0 -373.3 -271.3 -3649.0 -17.9 3 BULLISH -32.9
NAUT Nautilus Biotechnolgy, Inc. $410M -6.5 -41.0 -89.2 -6682.1 — 2 BULLISH 68.3
TCRT Alaunos Therapeutics, Inc. $10M -1.1 -185.9 -607.2 — -50.0 1 BULLISH -21.4
RARE Ultragenyx Pharmaceutical Inc. $1.5B -2.9 839.4 -67.5 -43.0 17.5 2 BULLISH -52.2
IUGNF Imugene Limited $30M -0.1 -389.5 -458.5 — -100.0 1 BULLISH -74.4
PCSA Processa Pharmaceuticals, Inc. $10M -0.3 -464.2 1977.5 — — 2 BULLISH -76.5
HEPA Hepion Pharmaceuticals, Inc. — -0.5 -125.6 710.2 — — 3 BULLISH 92.9
IMCR Immunocore Holdings plc $1.6B -176.2 -2.3 -472.0 -0.7 13.4 4 BULLISH -1.0
XERS Xeris Biopharma Holdings, Inc. $1.9B -107.0 118.2 18.3 -33.8 36.3 6 BULLISH 11.8
VSBC VitaSpring Biomedical Co. Ltd. $10M -13.8 10.3 15.9 — -100.0 4 BULLISH -96.8
IPIX Innovation Pharmaceuticals Inc. — -0.2 -115.7 -377.9 — -133.3 3 BULLISH -22.2
IMUC EOM Pharmaceuticals Holdings, Inc. $10M -4.9 64.4 131.0 — — 4 BULLISH 20.6
NBTX Nanobiotix S.A. $1.5B -27.5 104.2 62.0 -626.0 49.1 4 BULLISH 63.5
CKDXF Ceryvyn Therapeutics Ltd $10M 0.1 -243.9 2882.8 — -97.3 3 BULLISH -97.6
ZEOX Zeo ScientifiX, Inc. $10M -2.0 -140.0 105.8 -5.6 — 2 BULLISH —
CYYNF Cynata Therapeutics Limited — -0.3 -326.4 584.9 — -100.0 1 BULLISH -93.9
DMRA Damora Therapeutics, Inc. $1.3B — — — — — — BULLISH —
VIR Vir Biotechnology, Inc. $1.8B -6.2 -26.1 -38.8 33.5 1495.9 5 BULLISH 91.0
SLGL Sol-Gel Technologies Ltd. $230M -12.4 -35.9 -228.0 36.4 282.9 3 BULLISH 74.5
CYDY CytoDyn Inc. $380M -4.9 57.8 24.6 — 100.0 4 BULLISH -5.6
PDSB PDS Biotechnology Corporation $60M -2.1 -544.0 456.9 — — 1 BULLISH 16.3
ABOS Acumen Pharmaceuticals, Inc. $140M -1.5 -162.7 466.8 — — 2 LEAN BULL 7.6
HOWL Werewolf Therapeutics, Inc. $50M -1.4 -119.9 354.7 17.5 — 4 LEAN BULL -37.5
ATOS Atossa Therapeutics, Inc. $30M -0.6 -89.2 -4213.1 — — 2 LEAN BULL -82.2
ARDS Aridis Pharmaceuticals, Inc. — -0.0 4.8 10.0 -19.9 2227.6 4 LEAN BULL -92.3
INFIQ Infinity Pharmaceuticals, Inc. — -0.0 109.5 60.9 -1707.7 — 2 LEAN BULL 0.0
PPCB Propanc Biopharma, Inc. — -0.1 -161.9 -166.7 — — 4 LEAN BULL 54.7
BSSP Baseline Productions, Inc. — -0.0 167.7 64.9 — — 2 LEAN BULL 100.0
PTCHF PureTech Health plc $390M 157.1 0.2 50.8 1890.6 7.7 4 LEAN BULL -5.4
ACHFF Arch Biopartners Inc. $40M -20.0 73.5 165.4 — 100.0 2 LEAN BULL -10.0
PRVCF PreveCeutical Medical Inc. $10M -16.7 9.9 96.4 — — 3 LEAN BULL -44.7
SGMT Sagimet Biosciences Inc. $310M -8.2 -24.4 -231.4 — — 3 LEAN BULL 30.4
ABPO Abpro Holdings, Inc. — — — — — — — LEAN BULL —
MLTX MoonLake Immunotherapeutics $1.0B -3.1 -67.4 2902.7 — — 1 LEAN BULL 24.8
NTRR Neutra Corp. — 2.0 -139.6 -802.5 -3.8 142.2 7 LEAN BULL -33.3
PXMD PaxMedica, Inc. Common Stock — -0.0 -7716.2 572.1 — — 2 LEAN BULL 600.0
BTAX Biostax Corp. — -0.0 7.3 5.8 — — 2 LEAN BULL 100.0
LYRA Lyra Therapeutics, Inc. — -0.0 -6595.0 -671.6 -99300.0 -74.1 4 LEAN BULL -97.7
REVB Revelation Biosciences, Inc. — -0.1 -154.8 1317.2 — — 4 LEAN BULL 195.0
NNVC NanoViricides, Inc. $40M -3.6 -101.5 -111.4 — — 3 LEAN BULL -4.9
HSTC HST Global, Inc. $210M -538.5 -2.5 -1.2 -13.7 564.0 5 LEAN BULL 349900.0
EVAX Evaxion Biotech A/S $20M -0.5 -109.8 -260.4 — 135.9 6 LEAN BULL -45.1
OCEA Ocean Biomedical, Inc. — -0.0 36.5 0.3 — — 1 LEAN BULL -20.0
RXRX Recursion Pharmaceuticals, Inc. $2.0B -3.9 -56.6 -99.7 -1708.0 -14.9 4 LEAN BULL -33.7
ENSC Ensysce Biosciences, Inc. $10M -0.2 -968.3 792.9 -220.8 -77.6 3 LEAN BULL -78.7
LCTX Lineage Cell Therapeutics, Inc. $250M -7.3 -59.0 -171.3 138.6 19.9 5 LEAN BULL -38.7
GDTC CytoMed Therapeutics Limited $10M -2.5 -66.1 -87.8 -1125.6 -11.3 0 LEAN BULL -61.9
OKYO OKYO Pharma Limited $70M -6.1 -263.8 88.0 — — 3 LEAN BULL -35.7
MBRX Moleculin Biotech, Inc. $10M -0.0 -1371.6 -494.1 — — 3 LEAN BULL -43.1
DNAG DNAPrint Genomics, Inc. — -0.0 63.1 -156.0 -826.7 -15.2 3 LEAN BULL 100.0
RBSH Rebus Holdings, Inc. — -0.0 -9.7 8.9 — — 2 LEAN BULL 0.0
OBX Obsidian Therapeutics Inc. $10M — — — — — — NEUTRAL —
STAB Statera Biopharma, Inc. — -0.0 -298.8 2085.4 -769.5 1459.1 3 NEUTRAL -50.0
LYEL Lyell Immunopharma, Inc. $230M -0.6 -93.3 -227.7 -1118875.0 -55.0 3 NEUTRAL -49.2
PRLD Prelude Therapeutics Incorporated $210M -4.9 -57.7 14236.3 -244.1 220.3 5 NEUTRAL 146.7
NMAD NOMAD Power Solutions, Inc. $50M — — — — — — NEUTRAL —
CNBX CNBX Pharmaceuticals Inc. — -1.0 17.8 13.3 — 100.0 3 NEUTRAL -50.0
CALC CalciMedica, Inc. — -0.2 -365.7 118.3 — — 4 NEUTRAL -91.5
NWBO Northwest Biotherapeutics, Inc. $260M -6.7 55.8 -188.7 -1142.6 98.6 3 NEUTRAL -16.3
MLLCF Molecular Partners AG $150M -2.3 -62.1 650.3 — -100.0 2 NEUTRAL 14.6
EHOS Ehouse Global, Inc. — -0.0 161.0 52.5 — — 1 NEUTRAL 0.0
HESG Health Sciences Group, Inc. — -0.0 69.4 44.6 -19219.1 101.6 3 NEUTRAL 900.0
REPL Replimune Group, Inc. $1.1B -4.2 -134.3 -1055.2 — — 1 NEUTRAL 48.1
RGIN Regenicin, Inc. — -0.0 16.9 4.1 — — 4 NEUTRAL 0.0
RCAR RenovaCare, Inc. — -0.0 -436.6 812.3 — — 2 NEUTRAL 9900.0
NMTRQ 9 Meters Biopharma, Inc. — — — — — — — NEUTRAL 900.0
CFRXQ ContraFect Corp. — -0.0 544.7 276.9 — — 1 NEUTRAL -90.0
LYCA Lycia Therapeutics Inc. $1.6B — — — — — — N/A —
CTY City Therapeutics Inc. $200M — — — — — — N/A —
IAM Iambic Therapeutics Inc. $130M — — — — — — N/A —
LONA LeonaBio, Inc. $20M — — — — — — NEUTRAL —
JUNS Jupiter Neurosciences, Inc. — -0.1 -1888.7 5586.0 -9380.9 — 3 NEUTRAL -97.4
PHMMF Pharma Mar, S.A. $1.6B 21.2 24.9 35.9 -2.0 15.5 7 NEUTRAL 1.7
SRZN Surrozen, Inc. $190M -0.7 387.2 11.1 1003.5 -8.8 2 NEUTRAL 99.0
KLDO Kaleido Biosciences, Inc. — -0.0 -591.2 1121.9 -4292.5 13.2 2 NEUTRAL -80.0
YARW Yarrow Bioscience Inc $180M — — — — — — NEUTRAL —
ELUT Elutia Inc $40M 0.6 -397.0 -290.2 -315.0 -48.8 6 NEUTRAL -11.9
GSTC GlobeStar Therapeutics Corporation — -0.0 60.9 49.1 — — 4 NEUTRAL 9900.0
BPTH Bio-Path Holdings, Inc. — -0.0 49.0 15.2 — -100.0 1 NEUTRAL -99.6
ABVC ABVC BioPharma, Inc. $30M -3.6 -82.2 -43.0 — -100.0 2 NEUTRAL -64.0
USRM U.S. Stem Cell, Inc. — -0.0 20.8 23.4 -2836.8 -59.1 5 NEUTRAL 100.0
VCRE Vicore Pharma Holding AB $260M — — — — — — NEUTRAL —
KROS Keros Therapeutics, Inc. $220M -3.1 -17.2 -392.2 — -93.6 3 NEUTRAL -23.9
ENGNW enGene Holdings Inc. Warrants $10M -5.6 -2.3 134.1 — -100.0 2 NEUTRAL -64.6
PULM Pulmatrix, Inc. $10M -1.3 -98.3 -835.1 — -100.0 3 NEUTRAL -70.3
ANAB AnaptysBio, Inc. $1.5B 7.3 -1146.3 466.0 668.9 92.9 5 NEUTRAL 115.1
MRPI Mera Pharmaceuticals, Inc. — -10000.0 24.3 18.3 -159.9 4.8 5 NEUTRAL 0.0
KNBIF Kane Biotech Inc. — -2.4 439.7 -2166.6 -10238.1 -97.9 2 NEUTRAL -37.9
LIANY LianMedical — 1.1 74.7 -612.1 — — 6 NEUTRAL -15.0
ODTX Odyssey Therapeutics, Inc. $940M — — — — — — LEAN BEAR —
INRLF Valneva SE $640M -2.8 -118.0 -54.8 -89.3 -27.2 1 LEAN BEAR -25.4
POLBF Poolbeg Pharma PLC $70M -8.5 -58.8 -255.9 — — 1 LEAN BEAR 125.4
CLYYF Celyad Oncology S.A. $10M 2.5 -11.7 -979.7 64360.6 -88.7 5 LEAN BEAR -31.7
PLUR Pluri Inc. $10M -0.5 163.6 -483.9 -1755.2 -24.0 2 LEAN BEAR -73.2
GBIM GlobeImmune, Inc. — -0.0 -66.2 25.0 -91.5 55.1 4 LEAN BEAR 0.0
INVA Innoviva, Inc. $1.5B 4.3 36.7 15.0 -69.8 19.8 7 LEAN BEAR 15.3
MDNAF Medicenna Therapeutics Corp. $20M — — — — — — LEAN BEAR —
ONCSQ OncoSec Medical Incorporated — -0.0 -410.2 452.1 — — 2 LEAN BEAR -90.0
BIXT Bioxytran, Inc. — -0.7 92.2 68.7 — — 4 LEAN BEAR -64.9
NKGN NKGen Biotech, Inc. — -0.0 150.9 — -4511.3 — 3 LEAN BEAR -47.5
HLSQ Tessera Defense and Homeland Security Inc — — — — — — — LEAN BEAR —
EMMA Emmaus Life Sciences, Inc. — -0.4 9.9 -9.3 21.2 11.0 4 LEAN BEAR 351.0
REPCF RepliCel Life Sciences Inc. — -9.4 -248.8 -13.9 -80.9 200.0 6 LEAN BEAR 0.0
MCET MultiCell Technologies, Inc. — -0.1 101.2 99.1 -81.8 1532.7 5 LEAN BEAR 900.0
CMND Clearmind Medicine Inc. — -0.1 -104.0 593.4 — — 2 LEAN BEAR -99.8
NURPF Neuren Pharmaceuticals Limited $1.8B 118.1 6.2 22.4 14.6 -68.5 5 LEAN BEAR 20.8
DTIL Precision BioSciences, Inc. $180M -2.4 -135.1 203.1 — 3473.0 5 LEAN BEAR -7.5
PEPG PepGen Inc. $170M -1.7 -75.5 -327.5 — — 4 LEAN BEAR -44.7
MMIRF MedMira Inc. $30M -11.4 11.8 21.7 -200.5 45.7 4 LEAN BEAR -20.4
JBIO Jade Biosciences, Inc. $930M -5.4 -47.8 629.9 — — 3 LEAN BEAR 46.0
ACRS Aclaris Therapeutics, Inc. $550M -6.6 -59.1 -206.5 -1320.1 -51.0 3 LEAN BEAR 67.7
PARD Poniard Pharmaceuticals, Inc. — -0.0 -210.4 -442.5 — — 3 LEAN BEAR 0.0
KRSA Korsana Biosciences, Inc. $150M — — — — — — LEAN BEAR —
AOBI American Oriental Bioengineering, Inc. — -0.0 -28.2 -16.5 -118.1 -10.2 3 LEAN BEAR 1081.8
TYRA Tyra Biosciences, Inc. $1.2B -8.9 -45.3 -2390.9 — — 2 LEAN BEAR 44.6
IMMB Immunotech Laboratories, Inc. — — — — — — — LEAN BEAR 100.0
FPMI FluoroPharma Medical, Inc. — -0.0 22.7 39.7 — — 2 LEAN BEAR 100.0
GBLX GB Sciences, Inc. — -0.0 19.5 17.2 -103.2 — 3 LEAN BEAR -66.7
ZBIO Zenas BioPharma, Inc. $1.8B -2.9 -199.0 5842.1 -11145.6 -93.3 2 LEAN BEAR 8.9
ENTA Enanta Pharmaceuticals, Inc. $340M -5.0 -70.1 141.5 -135.8 0.7 4 LEAN BEAR 12.5
APLMW Apollomics, Inc. $170M -2.6 -233.7 845.7 1188.0 -75.9 3 LEAN BEAR -60.0
ARMP Armata Pharmaceuticals, Inc. $140M -0.7 127.8 -54.7 2953.8 -35.1 2 LEAN BEAR -51.4
NTHI Neonc Technologies Holdings, Inc. $90M — — — — — — LEAN BEAR -66.2
SRBCF Sirona Biochem Corp. — -0.7 111.4 1025.7 -34808.5 -119.4 2 LEAN BEAR -50.5
PZRXQ PhaseRx, Inc. — -0.0 -228.2 8803.4 — — 2 LEAN BEAR 0.0
RNAZ TransCode Therapeutics, Inc. — -0.0 -59.2 -21.0 — — 1 LEAN BEAR -87.0
NNBP Nanobac Pharmaceuticals, Incorporated — 0.0 358.0 221.2 -26718.6 -92.2 3 LEAN BEAR 0.0
NNLX NanoLogix, Inc. — — — — — — — LEAN BEAR -20.0
CLAZF Claritas Pharmaceuticals, Inc. — 0.0 -170.1 15.9 — — 3 LEAN BEAR 0.0
IMVIF IMV Inc. — -0.2 -503.3 -2870.5 — — 1 LEAN BEAR 1900.0
PREDQ Predictive Discovery Limited — — — — — — — LEAN BEAR —
FGHQF Frontage Holdings Corporation $360M 36.5 3.1 3.0 4.6 9.8 7 LEAN BEAR 16.8
GWIN Glorywin Entertainment Group, Inc. $360M -26081.4 11.7 5.1 — — 1 LEAN BEAR 229.5
SPHRY Starpharma Holdings Limited $220M -26.0 -46.5 -441.4 -725.1 186.8 4 LEAN BEAR 100.0
KNTPF Kintor Pharmaceutical Limited $120M -2.9 -116.6 -74.4 -145.6 2237.9 3 LEAN BEAR -10.2
LVCLF Algorae Pharmaceuticals Limited $20M -5.4 -47.4 -24288.6 — -100.0 3 LEAN BEAR 51.6
BCLI Brainstorm Cell Therapeutics Inc. $10M -0.8 119.2 76.7 — -100.0 1 LEAN BEAR 11.9
QPTFF Quest PharmaTech Inc. $10M 1.6 3.9 -1.7 — — 4 LEAN BEAR 125.6
FORU ForU Holdings, Inc. — -0.0 759.2 -476.4 — -100.0 2 LEAN BEAR 100.0
CHNXF ChitogenX Inc. — -0.2 23.2 36.2 — — 2 LEAN BEAR 48.0
CLGN CollPlant Biotechnologies Ltd. — -0.4 -162.0 -369.3 -2524.1 -86.8 2 LEAN BEAR -83.5
VINC Vincerx Pharma, Inc. — -0.0 -3136.4 910.2 — -18.7 5 LEAN BEAR -55.9
ALEC Alector, Inc. $200M -1.9 -385.1 66.8 -692.5 -82.9 1 LEAN BEAR 24.5
RLYB Rallybio Corporation $90M 3.4 34.5 -1198.7 — -35.6 6 LEAN BEAR 2640.0
AEON AEON Biopharma, Inc. $10M -0.1 350.0 98.0 — — 2 LEAN BEAR -73.6
ATXI Avenue Therapeutics, Inc. — -0.5 -120.0 178.4 — -100.0 2 LEAN BEAR -41.9
STOK Stoke Therapeutics, Inc. $1.6B -7.8 -61.1 -318.5 -660.8 -86.2 2 LEAN BEAR -19.7
CURX Curanex Pharmaceuticals Inc Common Stock $10M -0.6 -218.7 -392.2 — — 1 LEAN BEAR -62.8
ENZC Enzolytics Inc. — -11.2 105.9 1.4 — — 7 BEARISH 66.7
AVLN Avalyn Pharma Inc. Common Stock $1.1B — — — — — — BEARISH —
DBVT DBV Technologies S.A. $230M -2.6 -142.6 -2201.5 — -100.0 2 BEARISH -32.8
RNA Atrium Therapeutics, Inc. $140M -2.1 -36.9 455.9 -672.0 235.3 5 BEARISH -82.8
PBIGF Paradigm Biopharmaceuticals Limited $10M -1.6 -456.6 1081.8 -60158.9 53.6 4 BEARISH -95.6
PKTX ProtoKinetix, Incorporated — -1.0 -117.2 -115.0 — — 2 BEARISH -95.6
CARM Carisma Therapeutics, Inc. — 0.0 -134.1 -376.4 98.8 159.7 3 BEARISH -99.2
TRVN Trevena, Inc. — -0.0 344.3 -3198.4 -1745.2 -82.9 3 BEARISH -7.5
DRUG Bright Minds Biosciences Inc. $520M -26.2 -13.7 -105758.3 — — 3 BEARISH -17.0
TRDA Entrada Therapeutics, Inc. $170M -1.1 -54.1 -236.6 -4762.0 -94.1 1 BEARISH -25.8
BDTX Black Diamond Therapeutics, Inc. $110M -2.4 -37.2 -1604.9 — -100.0 1 BEARISH -56.4
INNMF Amplia Therapeutics Limited $30M -4.7 -24.9 -86.9 — -100.0 2 BEARISH -45.0
KPTI Karyopharm Therapeutics Inc. $10M -0.0 79.0 36.3 -200.5 6.8 2 BEARISH -92.2
AAGH America Great Health — 2.0 -12.2 22.4 -635.8 -5.1 4 BEARISH 100.0
BXRXQ Baudax Bio, Inc. — — — — — — — BEARISH 900.0
ADXN Addex Therapeutics Ltd — -0.4 -150.5 -168.4 -17543.0 -48.1 2 BEARISH -70.6
ABSI Absci Corporation $1.6B -13.4 -57.7 -213.1 -10443.4 -62.3 5 BEARISH 120.8
SNBIF SanBio Company Limited $1.3B -19.5 -55.8 -2935.2 — — 3 BEARISH 0.0
FATE Fate Therapeutics, Inc. $250M -2.0 -60.7 -140.1 -1448.6 -23.4 2 BEARISH 106.0
DYAI Dyadic International, Inc. $20M -1.9 522.6 1288.0 -221.0 1.5 3 BEARISH -64.8
BIVI BioVie Inc. $10M -0.4 -0.0 -0.0 — — 3 BEARISH -29.6
LSTA Lisata Therapeutics, Inc. $10M -0.6 -99.9 590.1 — -90.7 2 BEARISH -54.9
XCUR Exicure, Inc. $10M -0.8 -168.4 779.8 — — 2 BEARISH -77.0
VRCI Verde Science, Inc. — -0.0 72.3 23.0 — — 5 BEARISH 100.0
HLUN HEALTHeUNIVERSE, Inc. — — — — — — — BEARISH 900.0
SNNAQ Sienna Biopharmaceuticals, Inc. — -0.0 -140.9 -331.4 — — 2 BEARISH 0.0
NTII Neurobiological Technologies, Inc. — 0.0 48.7 441.6 89.7 99.7 4 BEARISH 0.0
CMRA Comera Life Sciences Holdings, Inc. — -0.0 235.6 124.2 -1580.0 81.8 4 BEARISH 0.0
HAVLF HAVN Life Sciences Inc. — -0.0 -275.3 -163.4 5734.1 876.8 3 BEARISH 0.0
GLSHQ Gelesis Holdings, Inc. — -0.0 391.0 -233.6 -693.9 -45.8 3 BEARISH 0.0
PSYBF PsyBio Therapeutics Corp — -0.0 344.6 135.0 — — 2 BEARISH -90.0
MRZM Marizyme, Inc. — -0.0 117.5 -190.1 — -69.0 3 BEARISH 0.0
TLOG TetraLogic Pharmaceuticals Corporation — -0.0 382.3 479.8 — — 1 BEARISH 0.0
NTLA Intellia Therapeutics, Inc. $1.6B -3.6 -55.4 -92.1 -1392.3 12.6 5 BEARISH -56.5
JANX Janux Therapeutics, Inc. $1.0B -10.4 -10.7 516.9 -214.0 7162.0 4 BEARISH -31.8
BPMUF Basilea Pharmaceutica AG $960M 16.9 39.5 75.9 23.5 4.5 7 BEARISH 27.1
BETRF BetterLife Pharma Inc. $110M -10.0 34.9 21.6 — — 4 BEARISH 220.0
SYGGF Synairgen plc — -0.2 -71.9 -381.4 — — 1 BEARISH -50.0
VAXX Vaxxinity, Inc. — -0.2 -150.6 2534.7 — — 0 BEARISH 0.0
PVLA Palvella Therapeutics, Inc. $1.8B -27.4 -46.6 137.5 — — 3 BEARISH 77.0
IFRX InflaRx N.V. $230M -3.0 -38.5 251.5 — -106.2 4 BEARISH 29.5
ATGGF Actinogen Medical Limited $140M -8.5 -77.5 -235.8 — -100.0 1 BEARISH 40.0
SQZB SQZ Biotechnologies Company — -0.0 -203.4 -410.2 — -44.6 0 BEARISH 4.3
MEOBF Mesoblast Limited $2.0B -29.4 -9.9 -14.4 -23.4 613.8 5 BEARISH -9.0
CLNN Clene Inc. $60M -1.1 237.2 132.5 -14915.6 -31.1 2 BEARISH -52.9
CEROW CERo Therapeutics Holdings, Inc. — -0.0 101.5 60.5 — -100.0 1 BEARISH -75.2
OCS Oculis Holding AG $490M -4.7 -44.0 -31.0 — -6.9 3 BEARISH -62.7
ALXO ALX Oncology Holdings Inc. $160M -1.0 -80.6 -851.1 — — 4 BEARISH -35.4
FBIOP Fortress Biotech, Inc. $130M 0.6 107.5 -87.8 -2.5 15.5 6 BEARISH 140.0
FHTX Foghorn Therapeutics Inc. $120M -2.0 81.9 26.3 -44.7 52.0 4 BEARISH -47.4
AURX Nuo Therapeutics, Inc. $60M -31.1 170.6 280.3 -15.7 166.6 3 BEARISH -47.8
VRPX Virpax Pharmaceuticals, Inc. — -0.0 2.6 0.4 — — 1 BEARISH -92.7
PBMWW Psyence Biomedical Ltd. Warrant — — — — — — — BEARISH -49.9
JAGX Jaguar Health, Inc. — -0.0 -501.9 -118.9 -1035.3 135.5 4 BEARISH -99.8
HTDS Hard to Treat Diseases Inc. — — — — — — — BEARISH 0.0
CALA Calithera Biosciences, Inc. — -0.0 -141.5 979.6 — -100.0 1 BEARISH 0.0
KARD Kardigan, Inc. $1.1B — — — — — — BEARISH —
PPTDF PeptiDream Inc. $870M -38.0 -7.1 -9.6 -25.7 47.8 4 BEARISH -38.7
EQ Equillium, Inc. $80M -5.2 -59.0 2703.6 — -100.0 3 BEARISH -6.0
LOBEF Lobe Sciences Ltd. $10M -2.7 359.0 181.6 — — 2 BEARISH 0.7
SNTI Senti Biosciences, Inc. $10M -0.1 -466.5 -430.9 -75000.0 — 2 BEARISH -91.2
SRPT Sarepta Therapeutics, Inc. $1.9B -13.0 -9.5 -6.3 -1.2 -20.4 4 BEARISH -17.9
CSPHF CStone Pharmaceuticals $1.4B -14.4 -51.4 -340.2 -123.0 135.6 5 BEARISH -15.4
DRTSW Alpha Tau Medical Ltd. $1.2B -13.0 -141.7 -17.1 — — 3 BEARISH 614.5
OVID Ovid Therapeutics Inc. $420M -4.7 -26.0 -43.7 -2047.6 -76.2 3 BEARISH 37.8
NGNE Neurogene Inc. $370M -4.9 -45.3 -111469.0 — — 2 BEARISH -18.0
DTCFF Defence Therapeutics Inc. $20M -3.8 -237.8 -86.8 — — 4 BEARISH -52.8
MRKR Marker Therapeutics, Inc. $20M -2.0 -76.9 -1014.3 — -77.1 2 BEARISH -8.9
PROT Proteonomix, Inc. — -0.0 77.5 -1239.4 — -63.1 4 BEARISH 0.0
SIGY Sigyn Therapeutics, Inc. — -0.0 61.7 32.8 — -100.0 1 BEARISH -98.5
BRAXF Braxia Scientific Corp. — -0.1 -254.6 -2393.3 -184.2 27.6 3 BEARISH -99.9
EFTR eFFECTOR Therapeutics, Inc. — -0.0 1737.6 607.9 — -91.9 4 BEARISH 0.0
RNUGF ReNeuron Group plc — -0.0 -106.8 210.1 -1809.6 -68.2 1 BEARISH 0.0
PANC Panacos Pharmaceuticals, Inc. — -0.0 -168.8 -792.8 -33966.7 -45.9 1 BEARISH 0.0
SYVC Synovics Pharmaceuticals, Inc. — — — — — — — BEARISH 0.0
CDXI Cardax, Inc. — -0.0 81.1 38.5 -1740.8 -27.3 2 BEARISH 0.0
PFND Pathfinder Cell Therapy, Inc. — -0.0 22.4 46.3 — — 2 BEARISH 0.0
NBIO Nascent Biotech, Inc. — -0.0 230.6 328.8 — — 5 BEARISH -75.0
ADYX Adynxx, Inc. — -0.0 1148.3 259.7 — -95.1 2 BEARISH 0.0
LADX LadRx Corporation — -0.0 278.9 118.4 — -61.0 1 BEARISH -99.0
RAPP Rapport Therapeutics, Inc. Common Stock $1.2B -9.1 -40.0 3981.5 — — 4 BEARISH -3.3
CGEM Cullinan Therapeutics, Inc. $880M -4.4 -50.3 1635.6 — — 1 BEARISH 88.1
VICP Vicapsys Life Sciences, Inc. $10M -20.5 31.3 17.6 — — 5 BEARISH -77.4
CNSP CNS Pharmaceuticals, Inc. $10M -0.2 -106.6 748.6 — — 3 BEARISH -42.5
ADRX ADARx Pharmaceuticals, Inc. $1.9B — — — — — — BEARISH —
CASIF CASI Pharmaceuticals, Inc. — — — — — — — BEARISH —
CRVS Corvus Pharmaceuticals, Inc. $890M -16.5 -35.4 -415.6 — — 4 BEARISH 46.0
GLSI Greenwich LifeSciences, Inc. $240M -11.0 -951.6 299.9 — — 2 BEARISH 86.4
ADAPY Adaptimmune Therapeutics plc $10M -0.1 -1341.1 268.4 -221.8 -54.0 0 BEARISH -64.1
TSHA Taysha Gene Therapies, Inc. $1.3B -10.1 -47.1 961.0 — -32.3 3 BEARISH -18.8
ARVN Arvinas, Inc. $470M 39.1 1.6 -519.3 67.8 -15.0 4 BEARISH -20.2
PRTA Prothena Corporation plc $420M -10.5 -14.4 -871.5 -1839.9 427.3 5 BEARISH -13.8
CCCC C4 Therapeutics, Inc. $380M -3.2 -48.1 -175.0 -355.9 2.3 4 BEARISH 25.2
ELTX Elicio Therapeutics, Inc. $40M -0.8 -774.6 2147.3 — — 4 BEARISH -82.1
DVHGF Devonian Health Group, Inc. $20M — -76.1 -75.1 -1098.1 -91.5 1 BEARISH 37.7
LEXX Lexaria Bioscience Corp. $10M -0.6 -150.3 -504.2 — -68.5 4 BEARISH -77.8
ALLR Allarity Therapeutics, Inc. $10M -1.2 -157.1 -96.5 — — 2 BEARISH -34.2
ANEB Anebulo Pharmaceuticals, Inc. $10M -1.7 -69.7 650.7 — — 1 BEARISH -89.9
SCPS Scopus BioPharma Inc. — -0.0 132.3 53.6 — — 2 BEARISH 33.3
RLFTY MindMaze Therapeutics Holding S.A. — -4.6 -36.8 -30.3 -1182.3 -95.8 2 BEARISH -95.2
BITRF Biotron Limited — -3.6 -87.5 -87.8 -113.4 -71.0 0 BEARISH 0.0
BIORQ Biora Therapeutics, Inc. — — — — — — — BEARISH —
SLXN Silexion Therapeutics Ltd. — -0.0 -17022.0 -931.4 — — 3 BEARISH -94.5
THER Theralink Technologies, Inc. — -0.0 6.0 -69.7 5363.6 32.8 2 BEARISH 0.0
AAPG Ascentage Pharma Group International $1.4B -6.1 -236.8 -144.8 -270.2 170.9 3 BEARISH -55.2
EDIT Editas Medicine, Inc. $370M -3.4 -118.8 71.4 -153.3 20.8 4 BEARISH -34.2
TTRX Turn Therapeutics Inc. $310M -36.1 -952.4 115.0 — — 2 BEARISH 114.3
NTRB Nutriband Inc. $70M -10.6 -100.7 -264.9 -201.3 -37.3 3 BEARISH -14.7
CSBR Champions Oncology, Inc. $70M -60.8 -30.7 -7.8 -2.8 6.7 3 BEARISH -28.0
HRGN Harvard Apparatus Regenerative Technology Inc. $30M -4.9 239.0 256.6 -409.4 — 2 BEARISH —
JSPR Jasper Therapeutics, Inc. $20M -0.3 -255.0 773.9 — — 2 BEARISH -78.3
APUS Apimeds Pharmaceuticals US, Inc — -0.1 -100.1 -12.6 — — 2 BEARISH -83.8
IBOGF Universal Ibogaine Inc. — -0.5 -94.8 5.5 -9.4 208.2 4 BEARISH -98.4
ERNA Ernexa Therapeutics Inc. — -0.1 -320.7 626.9 — -100.0 5 BEARISH -93.4
VRAX Virax Biolabs Group Limited — -0.0 -110.9 -481.7 -40439.1 121.6 4 BEARISH 101.7
PHRRF PharmaTher Holdings Ltd. — -7.6 -76.9 234.4 — — 2 BEARISH -51.7
MRES Institute of Biomedical Research Corp. — -2.3 301783.0 -6062.7 — — 1 BEARISH -80.1
SCNI Scinai Immunotherapeutics Ltd. — -0.0 -19.2 -53.3 -435.4 162.7 2 BEARISH -62.7
DNA Ginkgo Bioworks Holdings, Inc. $670M -2.3 -56.3 -44.0 -231.7 -51.5 2 BEARISH -24.4
INKT MiNK Therapeutics, Inc. $50M -4.4 57.9 42.8 — — 4 BEARISH -26.3
HOPHF Hemogenyx Pharmaceuticals Plc $20M -3.7 -628.5 -474.6 — — 4 BEARISH 0.0
HNSBF Hansa Biopharma AB (publ) $330M -4.6 159.8 1182.7 -541.7 -3.7 2 BEARISH -28.2
INTI Inhibitor Therapeutics, Inc. $10M -3.2 358.8 88.0 — — 1 BEARISH 22.2
ORGS Orgenesis Inc. — -0.2 764.3 1083.0 2628.2 -192.0 1 BEARISH -81.3
AFFY Affymax, Inc. — -0.0 98.1 -302.0 17164.3 -99.9 5 BEARISH -11.1
PLYX Polaryx Therapeutics, Inc. Common Stock $90M -15.3 -35.9 437.3 — — 2 BEARISH —
VBIZF Viva Biotech Holdings $400M 13.1 4.5 4.2 8.0 2.9 7 BEARISH -35.1
SPRB Spruce Biosciences, Inc. $130M -1.1 -106.0 772.2 — -100.0 4 BEARISH -66.1
OKUR OnKure Therapeutics, Inc. $100M -0.7 -46.9 1464.5 — — 4 BEARISH -16.8
SYRS Syros Pharmaceuticals, Inc. — -0.0 -777.0 960.6 — -90.5 0 BEARISH -33.3
IMTX Immatics N.V. $1.1B -4.1 -47.8 -858.3 -683.4 -68.0 2 BEARISH -29.8
AVBP ArriVent BioPharma, Inc. $1.0B -4.1 -53.1 2345.1 — — 3 BEARISH -15.1
ZURA Zura Bio Limited $320M -3.8 -65.4 806.5 — — 2 BEARISH 6.0
CLVLF Clinuvel Pharmaceuticals Limited $250M 10.6 13.2 126.7 41.1 -1.1 6 BEARISH -32.0
BCYC Bicycle Therapeutics plc $250M -1.4 -32.3 -1197.0 -8002.1 217.4 4 BEARISH -53.3
CDXS Codexis, Inc. $140M -3.8 -69.4 -37.8 -80.5 35.9 3 BEARISH -49.8
RNXT RenovoRx, Inc. $60M -4.3 -125.2 4391.9 -320.2 198.5 3 BEARISH 13.9
SGMOQ Sangamo Therapeutics, Inc. $50M — — — — — — BEARISH —
SEOVF Sernova Corp. $30M -3.7 57.0 76.3 — — 3 BEARISH -37.2
SNANF Sona Nanotech Inc. $20M -12.9 526.4 236.5 — — 1 BEARISH -63.9
RVXCF Resverlogix Corp. $20M -1.6 11.5 25.3 — — 4 BEARISH -25.0
HMTXF Hemostemix Inc. $10M -2.0 69.9 190.1 — — 1 BEARISH -44.5
AMBS Amarantus BioScience Holdings, Inc. — -0.0 7.3 3.8 -4080.5 — 3 BEARISH -66.7
ANTH Anthera Pharmaceuticals, Inc. — -0.0 -251.4 1107.5 — — 1 BEARISH 0.0
BRTX BioRestorative Therapies, Inc. — -0.1 -241.1 2112.9 -9298.3 -8.5 3 BEARISH -95.2
ATRX Adhera Therapeutics Inc — -0.0 18.6 6.5 — — 1 BEARISH 0.0
AMPE Ampio Pharmaceuticals, Inc. — -0.0 -114.0 1652.6 -838.4 — 4 BEARISH 6681.5
LIPO Lipella Pharmaceuticals Inc. — -0.0 -361.8 4105.8 — -64.1 1 BEARISH -99.9
CVKD Cadrenal Therapeutics, Inc. Common Stock — -0.2 -275.2 -540.4 — — 3 BEARISH -93.2
MAJI Nextel Medical Corp. — 0.6 -2.6 42.9 — — 1 BEARISH —
AURA Aura Biosciences, Inc. $650M -3.5 -53.5 -1360.0 — — 4 BEARISH 8.8
ARCT Arcturus Therapeutics Holdings Inc. $280M -3.4 -46.3 -2501.0 -803.8 -79.1 1 BEARISH -17.4
ATRA Atara Biotherapeutics, Inc. $90M -7.1 46.3 30.3 -767.3 -96.7 2 BEARISH -40.9
IMRN Immuron Limited $10M -2.9 -40.2 -187.8 -54.4 -29.7 5 BEARISH -57.4
SKYE Skye Bioscience, Inc. $10M -0.1 -233.9 389.5 — — 3 BEARISH 8.3
ERNAW Ernexa Therapeutics Inc. Warrants — — — — — — — BEARISH —
CUBT Curative Biotechnology, Inc. — -1.9 31.0 15.3 — — 4 BEARISH -24.9
IDRSF Idorsia Ltd $1.4B -3.5 27.1 -344.5 -203.1 -8.1 1 BEARISH -7.6
QTTB Q32 Bio Inc. $260M 3.1 72.1 435.2 — — 5 BEARISH 201.8
BRIBF Brii Biosciences Limited $90M -3.3 -10.3 -62.6 — 22.5 4 BEARISH -46.0
AUTL Autolus Therapeutics plc $410M -1.5 -132.9 451.5 -85.6 292.0 3 BEARISH 2.0
BVAXF BioVaxys Technology Corp. — -0.9 310.6 48.4 — — 1 BEARISH -45.4
TELO Telomir Pharmaceuticals, Inc. Common Stock $70M -0.7 -213.1 3515.1 — — 4 BEARISH -30.4
RECEF Recce Pharmaceuticals Ltd $70M -6.0 151.4 200.5 — -100.0 2 BEARISH -56.0
CVM CEL-SCI Corporation $30M -0.6 -252.5 -142.9 — -100.0 4 BEARISH -82.3
SNGX Soligenix, Inc. $10M -0.3 -241.7 304.6 — — 4 BEARISH -87.3
ARTL Artelo Biosciences, Inc. $10M -0.0 -705.7 -1031.2 — — 5 BEARISH -92.8
LIFS Life Stem Genetics Inc. — -2.5 -126.7 -111.5 — — 2 BEARISH -50.0
FNAM Evolutionary Genomics, Inc. — -0.0 62.2 -99.6 — — 2 BEARISH 0.0
WINT Windtree Therapeutics, Inc. — -0.0 1111.0 -2375.5 — — 3 BEARISH -99.6
RGRX RegeneRx Biopharmaceuticals, Inc. — -0.0 53.5 45.8 -2006.3 -0.0 3 BEARISH 450.0
SYBE SYBLEU Inc — -3.1 71.5 -202.2 -685.7 — 2 BEARISH 0.0
BICTF Biocure Technology Inc. — -0.1 -889.9 60.0 — — 1 BEARISH 0.0
VOR Vor Biopharma Inc. $990M 0.1 -73.6 22.2 — — 3 BEARISH -34.0
ASCLF Ascletis Pharma Inc. $770M -7.8 -28.4 -7144.0 — -60.6 2 BEARISH -40.2
YDES YD Bio Limited Ordinary Shares $350M — — — — — — BEARISH -70.0
CAMP CAMP4 Therapeutics Corporation $210M -1.6 -545.9 48.4 -1884.8 40.2 2 BEARISH -7.8
RNAC Cartesian Therapeutics, Inc. $190M -1.1 241.0 37.3 — 44.0 2 BEARISH -30.2
VRXA Veraxa Biotech Holding AG $140M — — — — — — BEARISH —
OTLK Outlook Therapeutics, Inc. $130M -0.5 256.9 1372.0 -225766.7 -169.4 3 BEARISH -60.5
ONCY Oncolytics Biotech Inc. $50M -1.9 90135.4 285.1 — — 1 BEARISH -59.9
CNTB Connect Biopharma Holdings Limited $50M -0.9 -105.5 1034.1 -1249.0 49.8 2 BEARISH -47.6
ALPS Alps Group Inc $50M — — — — — — BEARISH —
CLCS Cell Source, Inc. $40M -4.6 27.7 34.5 — — 4 BEARISH 21.7
BYSI BeyondSpring Inc. $20M -2.9 20.3 15.7 — 100.0 2 BEARISH -77.2
CNTX Context Therapeutics Inc. $20M -0.5 -76.1 841.7 — — 2 BEARISH -81.3
PLRZ Polyrizon Ltd. $10M -2.0 -21.4 -68.2 — — 0 BEARISH 38.3
ADIL Adial Pharmaceuticals, Inc. $10M -0.2 -2011.6 159.6 — — 3 BEARISH -60.2
LPCN Lipocine Inc. $10M -0.8 -60.9 662.3 -1379.6 -62.7 2 BEARISH -48.8
GLWLF Glow Lifetech Corp. $10M -50.0 -11.1 -21.1 -26.6 59.2 5 BEARISH -19.5
KTTA Pasithea Therapeutics Corp. $10M -0.2 -65.5 -453.2 — — 4 BEARISH -45.2
ICU SeaStar Medical Holding Corporation $10M -0.6 -356.9 415.0 -606.5 123.6 4 BEARISH -60.9
ONCO Onconetix, Inc. — -0.1 -105.2 -83.7 -16748.3 -51.3 3 BEARISH -88.1
BBLG Bone Biologics Corporation — -0.2 -47.5 1744.6 — — 2 BEARISH -82.9
AFMDQ Affimed N.V. — — — — — — — BEARISH —
EVLO Evelo Biosciences, Inc. — -0.0 948.0 605.0 — — 2 BEARISH -80.0
VCNX Vaccinex, Inc. — -0.4 776.6 414.6 -1584.0 226.6 3 BEARISH -20.6
VIVS VivoSim Labs, Inc. — -0.0 -343.1 241.9 -7433.3 202.7 2 BEARISH -93.1
SXTP 60 Degrees Pharmaceuticals, Inc. — -0.1 -321.8 -390.2 -1089.2 68.0 3 BEARISH -40.1
SPRC SciSparc Ltd. — -0.0 -519.9 -161.9 -1891.2 -26.8 5 BEARISH -67.6
MTNB Matinas BioPharma Holdings, Inc. — -0.1 -154.3 -504.1 — — 4 BEARISH -93.1
NCEL NewcelX Ltd. — 8.0 -48.0 -39.1 — — 2 BEARISH —
DRMA Dermata Therapeutics, Inc. — -0.2 -183.9 734.5 — — 2 BEARISH -82.8
ITMC Itoco Inc. — -0.0 303.4 96.7 — — 2 BEARISH 0.0
OBIO Orchestra BioMed Holdings, Inc. $340M -5.6 -397.3 468.3 -26994.3 986.1 4 BEARISH 46.0
ACOG Alpha Cognition Inc $130M -8.1 -55.3 -198.4 -144.3 232.7 2 BEARISH -3.3
LITS Lite Strategy, Inc. $40M -0.1 -170.9 -28.2 — — 2 BEARISH -40.1
NXTC NextCure, Inc. $20M -0.5 -195.2 949.7 — — 2 BEARISH -41.2
BCTXZ BriaCell Therapeutics Corp. Warrant — -0.3 -168.1 -2016.9 — — 1 BEARISH -72.9
TRVI Trevi Therapeutics, Inc. $1.8B -39.6 -19.7 -1451.7 — — 3 BEARISH 17.5
QURE uniQure N.V. $1.6B -5.9 -157.6 37.9 -1387.8 30.2 4 BEARISH -63.5
MGTX MeiraGTx Holdings plc $880M 12.3 72.3 96.7 50.0 948.3 7 BEARISH 4.9
ABUS Arbutus Biopharma Corp $830M 5.4 89.6 86.7 -507.2 1078.8 4 BEARISH -1.9
AMGXF AnGes, Inc. $140M -3.0 -160.6 -111.8 -531.3 -16.1 4 BEARISH 0.0
BBIXF Bonus BioGroup Ltd. $50M -17.4 3245.0 2543.1 — — 2 BEARISH 100.0
XTLB XTL Biopharmaceuticals Ltd. — -0.6 -26.8 -38.7 -88.2 — 3 BEARISH 46.8
MYMX Mymetics Corporation — -0.0 16.6 357.9 -3012.0 -62.8 2 BEARISH 0.0
NWPHF Newron Pharmaceuticals S.p.A. $410M -6.7 83.9 -32.1 -513.4 — 1 BEARISH —
SRNE Sorrento Therapeutics, Inc. — -0.0 1502.8 468.4 -633.7 16.9 2 BEARISH -96.0
PBLA Panbela Therapeutics, Inc. — -0.0 270.3 240.0 — 100.0 3 BEARISH -91.0
CPMV Mosaic ImmunoEngineering Inc. — -2.0 9.2 7.5 — — 2 BEARISH -87.7
MNKD MannKind Corporation $1.0B -23.4 71.4 4.0 -17.4 30.5 2 BEARISH -41.2
APMD Apnimed, Inc. $790M — — — — — — BEARISH —
SABS SAB Biotherapeutics, Inc. $260M 0.9 -11.3 -48.4 — -100.0 3 BEARISH -4.5
IMRX Immuneering Corporation $240M -3.7 -52.1 -112.8 — — 4 BEARISH -34.1
HUMA Humacyte, Inc. $120M -0.9 -547.9 -500.7 -9064.5 -73.6 3 BEARISH -76.3
BTAIQ BioXcel Therapeutics, Inc. — — — — — — — BEARISH —
TSOI Therapeutic Solutions International, Inc. — -0.1 -187.6 -130.3 -5123.0 -99.7 4 BEARISH -99.0
BCRX BioCryst Pharmaceuticals, Inc. $1.9B -5.6 87.8 62.3 35.9 68.7 5 BEARISH 9.6
GENB Generate Biomedicines, Inc. $1.6B -7.9 -28.2 -175.0 -1065.2 — 1 BEARISH —
CMPS COMPASS Pathways plc $1.6B -2.1 -319.1 48.8 — — 2 BEARISH 77.1
INBX Inhibrx Biosciences Inc. $1.4B -11.2 -1773.6 55.8 — -100.0 4 BEARISH 212.4
OMER Omeros Corporation $1.2B 9.1 -89.2 71.8 46.4 — 5 BEARISH 112.9
ACHV Achieve Life Sciences, Inc. $670M -4.4 -845.0 24.6 — — 2 BEARISH 32.9
NVCT Nuvectis Pharma, Inc. $650M -14.0 -214.6 174.4 — — 1 BEARISH 207.7
MDXG MiMedx Group, Inc. $570M 96.6 2.9 5.8 -23.1 -2.4 6 BEARISH -42.0
STTK Shattuck Labs, Inc. $550M -11.4 -39.2 -29.3 — -66.6 4 BEARISH 199.5
CBIO Crescent Biopharma, Inc. $480M -1.8 -107.7 1928.6 — — 5 BEARISH -0.2
RZLT Rezolute, Inc. $370M -5.4 -59.0 1060.6 — — 2 BEARISH -57.6
FENC Fennec Pharmaceuticals Inc. $350M -81.5 -18.6 -76.2 11.0 77.8 6 BEARISH 13.3
DMTRF 3-D Matrix, Ltd. $310M 11.9 75.0 31.1 9.4 57.0 6 BEARISH 61.3
CUE Cue Biopharma, Inc. $140M -0.7 -1603.5 1241.9 -1943.2 354.4 3 BEARISH -21.2
VANI Vivani Medical, Inc. $100M -3.3 -220.4 -127.1 — — 4 BEARISH -30.7
MNOV MediciNova, Inc. $70M -6.5 -25.6 -78.2 -504.8 583.9 3 BEARISH 14.8
NDTP NDT Pharmaceuticals Inc. $50M -39.2 -3.8 -1.5 -458.3 — 4 BEARISH -77.5
CRVO CervoMed Inc. $30M -0.7 -107.6 1244.8 — — 2 BEARISH -68.4
CELU Celularity Inc. $30M -0.4 150.9 40592.8 13.0 -58.1 4 BEARISH -62.3
TELIF Telescope Innovations Corp. $20M 6.0 -229.2 -80.7 -116.8 66.3 2 BEARISH -15.9
COCP Cocrystal Pharma, Inc. $20M -1.2 -311.7 -3697.6 -3013.3 — 2 BEARISH -8.3
PVCT Provectus Biopharmaceuticals, Inc. $20M -4.3 78.1 83.4 — -100.0 5 BEARISH -29.7
LTRN Lantern Pharma Inc. $10M -0.4 -400.9 115.9 — — 2 BEARISH -83.6
PHYOF IXICO plc $10M -6.0 -15.8 -23.6 -28.5 13.2 2 BEARISH 0.0
PASG Passage Bio, Inc. $10M -0.3 -169.1 159.0 — — 3 BEARISH -55.2
CDT CDT Equity Inc. — -0.0 13.1 5.4 9.1 — 7 BEARISH -97.0
ADTX Aditxt, Inc. — -0.0 622.6 49.4 -131159.8 -74.1 1 BEARISH -100.0
YDESW YD Bio Limited Warrants — — — — — — — BEARISH -81.8
HMGN Hemagen Diagnostics, Inc. — -0.0 29.1 -24.6 -18.6 -21.4 2 BEARISH 100.0
YECO EV Biologics, Inc. — -0.0 16.2 18.1 18.6 264.7 5 BEARISH -99.9
LIMNW Liminatus Pharma, Inc. Warrants — -0.1 -4165.9 252.1 — — 2 BEARISH -83.3
AXIM AXIM Biotechnologies, Inc. — -1.6 3.0 24.9 -90.9 2142.6 5 BEARISH -60.0
RGBPP Regen BioPharma, Inc. — -0.0 20.3 12.8 -1079.8 0.0 4 BEARISH -98.5
CHMMF Chimeric Therapeutics Limited — -0.0 655.2 80.8 — -100.0 2 BEARISH 0.0
BLEG Branded Legacy, Inc. — -0.0 2011.7 147.0 — -29.4 2 BEARISH -99.5
GRI GRI Bio, Inc. — -0.0 -142.0 1227.5 — — 5 BEARISH -97.4
NMLSF Restart Life Sciences Corp. — -1.8 -214.3 -153.9 -307.0 — 2 BEARISH -69.2
AGNPF Grey Matters Health Inc. — — -140.9 -64.7 — — 3 BEARISH -58.6
LNAI Lunai Bioworks Inc. — -0.3 -21.6 30.2 — — 2 BEARISH -96.8
GHRS GH Research PLC $1.2B -20.0 -18.8 2015.5 — — 2 BEARISH 44.5
ANRO Alto Neuroscience, Inc. $860M -9.3 -49.2 -201.4 — — 3 BEARISH 97.7
AKTS Aktis Oncology, Inc. $850M -15.8 -29.9 276.4 -713.5 -36.1 5 BEARISH 245681.2
DSGN Design Therapeutics, Inc. $640M -9.1 -34.1 1787.8 — — 1 BEARISH 81.4
SLDB Solid Biosciences Inc. $630M -3.2 -65.5 -1012.6 — — 3 BEARISH 5.2
LXRX Lexicon Pharmaceuticals, Inc. $630M -9.8 -40.2 -99.7 -4591.8 -29.0 3 BEARISH 18.9
ANL Adlai Nortye Ltd. $560M -5.5 -22.4 -317.5 -36.3 223.4 4 BEARISH 537.4
MNPR Monopar Therapeutics Inc. $470M -30.7 -19.5 523.8 — — 2 BEARISH -13.2
AVIR Atea Pharmaceuticals, Inc. $320M -2.0 -58.1 974.6 — — 3 BEARISH 30.4
ARTV Artiva Biotherapeutics, Inc. $300M -1.3 -36.6 -954.6 — — 3 BEARISH 27.3
WHWK Whitehawk Therapeutics Inc $180M -3.0 -45.0 963.4 — -100.0 1 BEARISH 28.2
ANTX AN2 Therapeutics, Inc. $130M -3.5 -50.1 1243.3 — — 2 BEARISH 210.3
NRXP NRx Pharmaceuticals, Inc. $110M -3.6 131.2 61.3 -1500.5 — 5 BEARISH -20.3
ELOX Eloxx Pharmaceuticals, Inc. $40M -8.5 -107.5 81.5 — — 4 BEARISH 13029900.4
BMEA Biomea Fusion, Inc. $40M -1.2 -164.1 210.3 — — 2 BEARISH -53.9
TVGN Tevogen Bio Holdings Inc. $30M -1.2 235.3 244.1 — — 5 BEARISH 917.3
AVEFF Avecho Biotechnology Limited $20M -9.3 -268.2 103.4 -3227.5 -46.6 3 BEARISH 0.0
CMMB Chemomab Therapeutics Ltd. $10M -1.0 -82.7 -314.7 — — 1 BEARISH -65.3
KZIA Kazia Therapeutics Ltd ADR $10M -1.1 -104.5 62.7 — -99.2 4 BEARISH 16.8
SYBX Synlogic, Inc. $10M -19.6 -5.3 306.3 — — 2 BEARISH -39.0
XRTX XORTX Therapeutics Inc. — -0.4 -99.1 -68.5 — — 3 BEARISH 47.6
HXBM Helix BioMedix, Inc. — — — — — — — BEARISH -6.0
OZYMF Strategic Partners A/S — 19.0 0.8 -117.5 1019.0 — 6 BEARISH 0.0
GNLKQ GeneLink, Inc. — -0.0 73.0 82.1 -183.0 -33.6 3 BEARISH 0.0
RMTG Regenerative Medical Technology Group Inc. — -0.1 9.6 -3.3 -72.2 — 3 BEARISH —
GLABF Gemina Laboratories Ltd. — -3.0 42.7 32.4 -7838.5 — 5 BEARISH -78.3
HBMHF HBM Holdings Limited $1.3B 12.5 24.1 53.0 53.0 54.6 4 BEARISH -38.1
BCAX Bicara Therapeutics Inc. Common Stock $1.1B -5.6 -41.0 583.9 — — 2 BEARISH -0.2
NKTR Nektar Therapeutics $1.1B -5.7 -35.8 -29.2 -401.0 -27.2 3 BEARISH -41.1
GLUE Monte Rosa Therapeutics, Inc. $920M -4.8 -42.7 149.9 -483.9 -83.9 3 BEARISH 1.0
ALMS Alumis Inc. $880M -1.8 -93.6 2645.2 -8557.2 -63.1 2 BEARISH 41.2
AGMB AgomAb Therapeutics N.V. American Depositary Shares $450M — — — — — — BEARISH —
BLSM BlossomHill Therapeutics, Inc. $430M — — — — — — BEARISH —
EIKN Eikon Therapeutics, Inc. Common Stock $390M — — — — — — BEARISH —
RLMD Relmada Therapeutics, Inc. $350M -3.5 -55.7 460.5 — — 3 BEARISH 46.1
BNTC Benitec Biopharma Inc. $300M -8.9 -33.2 1840.8 — — 3 BEARISH -38.6
IPSC Century Therapeutics, Inc. $260M -1.4 -49.7 -60.0 — -100.0 2 BEARISH 140.7
RCKT Rocket Pharmaceuticals, Inc. $250M -15.5 -4.8 -137.8 — — 3 BEARISH -39.0
BOVNF BioInvent International AB (publ) $220M -2.8 -88.2 20101.5 -964.0 -87.2 1 BEARISH 0.0
CHRS Coherus Oncology, Inc. $160M -1.0 -145.4 1854.0 -144.2 -64.3 2 BEARISH -39.5
VXRT Vaxart, Inc. $100M 2.7 67.0 149.6 -49.6 201.1 6 BEARISH 12.5
IMUX Immunic, Inc. $100M -1.6 -138.2 345.6 — — 5 BEARISH -6.7
ADAG Adagene Inc. $90M -5.6 -28.6 111.8 -1011.1 8927.0 5 BEARISH 39.1
NMRA Neumora Therapeutics, Inc. Common Stock $70M -0.3 -187.1 231.9 — — 2 BEARISH -75.0
TENX Tenax Therapeutics, Inc. $50M -1.2 -59.8 1235.8 — — 1 BEARISH -77.6
IMA ImageneBio Inc $50M -0.8 -40.7 -594.7 — — 3 BEARISH -45.1
IBO Impact BioMedical Inc. $30M -3.0 10.8 -30.4 -23300.0 — 5 BEARISH -49.4
NEUP Neuphoria Therapeutics Inc. $20M -0.5 -0.2 -0.2 -417.7 -91.9 4 BEARISH -16.5
PRRUF Immutep Limited $20M -0.4 -77.3 1092.5 -328.8 255.0 3 BEARISH -89.5
CLRB Cellectar Biosciences, Inc. $10M -0.3 -119.6 717.6 — — 3 BEARISH -68.0
AIM AIM ImmunoTech Inc. $10M -0.0 -2382.3 -513.5 -14569.2 -21.5 5 BEARISH -93.2
CTXR Citius Pharmaceuticals, Inc. $10M -0.2 -70.3 -85.4 -593.3 4456.8 3 BEARISH -73.9
RADX Radiopharm Theranostics Limited — — — — — — — BEARISH -82.1
LGVN Longeveron Inc. — -0.2 -203.6 -2062.6 -2116.0 -42.7 4 BEARISH -81.1
APVO Aptevo Therapeutics Inc. — -0.0 -420.3 -4688.7 — — 1 BEARISH -94.5
ARNI Arno Therapeutics, Inc. — -0.0 250.7 111.6 — — 3 BEARISH 0.0
MYNDF MYND Life Sciences Inc. — -2.2 9.5 34.0 — — 5 BEARISH -41.3
SEPSF Asep Medical Holdings Inc — -0.3 -36.4 -75.5 -844.8 208.8 5 BEARISH -97.2
BIOAF Bioasis Technologies Inc. — -0.1 135.1 538.8 -661.8 614.1 2 BEARISH -50.0
ARUXF Acrux Limited — -7.1 -48.5 -74.2 -26.5 289.9 7 BEARISH -93.4
ORIC ORIC Pharmaceuticals, Inc. $1.4B -6.7 -39.8 -102.9 — — 3 BEARISH -27.9
KURA Kura Oncology, Inc. $850M -2.9 -167.7 56.3 -327.3 -7.3 1 BEARISH 5.7
FDMT 4D Molecular Therapeutics, Inc. $600M -4.3 -43.3 -182.0 -1929.0 278712.1 4 BEARISH 10.3
ZVRA Zevra Therapeutics, Inc. $580M 10.5 34.8 -1356.4 22.1 119.4 6 BEARISH -10.8
EPRX Eupraxia Pharmaceuticals Inc. $450M -6.9 -68.6 8742.2 — — 3 BEARISH 20.6
AGEN Agenus Inc. $290M 2.4 -33.2 -20.4 -1.6 30.5 6 BEARISH 47.4
IRD Opus Genetics, Inc. $290M -2.7 -4796.5 59.8 -1072.6 -36.1 3 BEARISH 66.0
GALT Galectin Therapeutics Inc. $210M -8.0 21.9 99.4 — — 2 BEARISH -37.8
CGEN Compugen Ltd. $180M 5.2 49.6 -90.2 -269.3 886.7 5 BEARISH 12.6
MGNX MacroGenics, Inc. $140M -10.8 -32.6 33.8 59.4 2.3 2 BEARISH 19.7
SEER Seer, Inc. $110M -1.6 -26.4 -58.8 -544.8 -13.3 3 BEARISH -11.1
COYA Coya Therapeutics, Inc. $90M -3.9 -60.5 -18820.6 -2723.4 1793.8 4 BEARISH -43.4
ACRV Acrivon Therapeutics, Inc. Common Stock $70M -0.9 -64.6 5251.5 — — 1 BEARISH -14.0
PMVP PMV Pharmaceuticals, Inc. $70M -0.9 -70.9 815.8 — — 2 BEARISH -28.5
HRTX Heron Therapeutics, Inc. $60M -1.6 334.6 -7.6 -14.6 1.0 3 BEARISH -74.7
OSTX OS Therapies Incorporated $60M -1.1 1924.5 268.9 — — 1 BEARISH -33.1
SPRO Spero Therapeutics, Inc. $60M 7.9 19.2 -128.5 — -7.0 7 BEARISH -51.4
XLO Xilio Therapeutics, Inc. $50M -4.9 -55.0 43.1 -34.1 327.3 6 BEARISH 845.5
AKTX Akari Therapeutics, Plc $20M -0.0 -139.9 -175.8 — — 3 BEARISH -74.2
KPRX Kiora Pharmaceuticals, Inc. $10M -0.9 -56.4 -2884.1 — — 2 BEARISH -13.0
OTLC Oncotelic Therapeutics, Inc. $10M 0.0 181.4 -1.4 155.3 — 5 BEARISH -82.0
ENVB Enveric Biosciences, Inc. $10M -0.1 -170.0 3225.6 — — 4 BEARISH -81.1
PTIX Protagenic Therapeutics, Inc. — 0.2 -485.4 -367.8 — 100.0 6 BEARISH -78.3
ISCO International Stem Cell Corporation — -2.4 30.4 -10.8 -2.7 3.4 6 BEARISH -6.7
PBM Psyence Biomedical Ltd. — — — — — — — BEARISH 9.9
RVLPQ RVL Pharmaceuticals plc — -0.0 -182.4 -101.1 -289.3 5.6 3 BEARISH -90.0
URGN UroGen Pharma Ltd. $1.7B -17.2 86.5 119.0 -19.8 169.5 2 BEARISH 96.4
NVAX Novavax, Inc. $1.6B -6.6 323.7 29.2 -94.2 -61.6 2 BEARISH 12.4
NUVB Nuvation Bio Inc. $1.6B -10.3 -47.8 70.2 -198.3 1083.6 4 BEARISH 2.7
DRTS Alpha Tau Medical Ltd $1.2B -13.0 -141.7 -17.1 — — 3 BEARISH 206.2
MDCLF MedinCell S.A. $1.1B -29.2 472.2 81.6 -152.1 -14.8 3 BEARISH 333.5
IMMX Immix Biopharma, Inc. $680M -9.3 -34.2 1509.2 — — 4 BEARISH 135.0
CADL Candel Therapeutics, Inc. $610M -5.9 -81.8 219.4 — — 2 BEARISH 46.7
CLYM Climb Bio, Inc. $590M -11.6 -27.1 -88.6 — — 2 BEARISH 342.7
GNFTF Genfit S.A. $470M -5.2 -5084.0 -322.7 -124.0 27.5 3 BEARISH 153.5
AVCTF Avacta Group Plc $420M -6.7 -2083.2 -753.6 -33970.3 -99.7 5 BEARISH -18.7
IKT Inhibikase Therapeutics, Inc. $220M -3.3 -52.0 920.5 — — 3 BEARISH -0.7
PLX Protalix BioTherapeutics, Inc. $210M 10.5 31.2 47.1 19.0 30.1 5 BEARISH 6.9
PRQR ProQR Therapeutics N.V. $180M -3.0 -57.9 139.7 -99.6 12.7 2 BEARISH -56.0
ORMP Oramed Pharmaceuticals Inc. $170M 1.0 74.1 -4.3 — -100.0 4 BEARISH 72.2
TRGNF Transgene S.A. $120M -4.1 -64.1 -184.9 -5760.7 -185.8 4 BEARISH -53.1
PYXS Pyxis Oncology, Inc. $110M -1.3 -179.1 1953.9 — 291.4 2 BEARISH -50.0
PRNAF Alterity Therapeutics Limited $50M -2.2 -55.0 -401.1 — -100.0 2 BEARISH 8233.3
BOLD Boundless Bio, Inc. $50M -0.8 -67.9 807.9 — — 2 BEARISH 68.8
BMNDF Biomind Labs Inc. $20M -13.3 85.8 101.7 — — 2 BEARISH 1483.5
SER Serina Therapeutics, Inc. $20M -0.9 -206.3 1868.6 — -100.0 3 BEARISH -67.9
ALZN Alzamend Neuro Inc $10M -0.5 -163.2 401.5 — — 1 BEARISH -52.4
XBIO Xenetic Biosciences, Inc. — -1.5 -47.0 523.4 -140.7 33.3 4 BEARISH -55.2
SNDX Syndax Pharmaceuticals, Inc. $1.2B -5.4 -255.9 -270.9 -67.8 222.3 4 BEARISH -9.9
ARDX Ardelyx, Inc. $770M -13.2 -38.6 -22.7 -13.8 16.8 4 BEARISH -40.7
GERN Geron Corporation $720M -11.5 -29.2 -74.1 -29.0 24.4 2 BEARISH -5.7
SANA Sana Biotechnology, Inc. $700M -3.2 -152.9 -242.3 — — 3 BEARISH -57.8
SLBT SL Science Holding Ltd $640M — — — — — — BEARISH —
WVE Wave Life Sciences Ltd. $630M -3.2 -80.0 -1243.7 -470.5 -35.1 4 BEARISH -54.5
GYRE Gyre Therapeutics, Inc. $620M -32.8 -15.6 -22.3 -36.4 16.8 3 BEARISH -26.2
ANNX Annexon, Inc. $610M -3.2 -105.3 -11323.3 — — 2 BEARISH 21.3
OLMA Olema Pharmaceuticals, Inc. $560M -3.3 -52.7 585.3 — — 2 BEARISH -18.2
CTMX CytomX Therapeutics, Inc. $510M -5.2 -37.8 305.9 -1457.4 -87.0 2 BEARISH -32.4
SPRY ARS Pharmaceuticals, Inc. $400M -1.7 -210.3 -424.3 -185.2 4.1 2 BEARISH -59.4
MPLT MapLight Therapeutics, Inc. $340M -1.6 -57.5 -366.6 — — 2 BEARISH —
SPHDF Santhera Pharmaceuticals Holding AG $280M -6.6 729.6 111.3 -44.5 106.3 7 BEARISH 49.1
VOGX Vogenx Inc. $260M — — — — — — BEARISH —
ORYZF Oryzon Genomics S.A. $250M -80.4 -3.0 -7.2 -1.6 12.6 4 BEARISH -14.1
VNDA Vanda Pharmaceuticals Inc. $240M -0.9 -77.8 -201.0 -123.7 6.0 3 BEARISH -28.2
LRMR Larimar Therapeutics, Inc. $240M -1.2 -139.6 590.9 — — 2 BEARISH -43.3
HLOSF Healios K.K. $240M 56.3 3.7 -129.2 17028.6 -47.1 4 BEARISH -48.6
LXEO Lexeo Therapeutics, Inc. Common Stock $230M -2.5 -46.8 -249.1 — — 3 BEARISH -70.0
IPHYF Innate Pharma S.A. $210M -2.5 267.9 119.2 -343.8 32.0 3 BEARISH -24.5
BBOT BridgeBio Oncology Therapeutics Inc. $210M -0.0 -56.4 -157.3 — — 1 BEARISH -75.7
ELDN Eledon Pharmaceuticals, Inc. $190M -2.4 -110.7 411.1 — — 2 BEARISH -32.8
BIOA BioAge Labs Inc. $190M -2.3 -28.2 -142.3 -1064.7 168.1 4 BEARISH -37.2
EVMN Evommune, Inc. $190M -1.5 -29.6 -82.4 — — 2 BEARISH —
AKBA Akebia Therapeutics, Inc. $160M -6.1 -109.4 15.6 -18.1 7.5 6 BEARISH -78.4
ZNTL Zentalis Pharmaceuticals, Inc. $160M -0.8 -83.7 -2245.4 — -100.0 2 BEARISH 26.2
NBP NovaBridge Biosciences $160M -2.2 -45.7 -617.8 — — 1 BEARISH -72.2
NGEN NervGen Pharma Corp. Common stock $150M — — — — — — BEARISH —
MDWD MediWound Ltd. $150M -7.7 -72.4 -255.1 -239.1 -40.3 2 BEARISH -34.8
TARA Protara Therapeutics, Inc. $140M -1.8 -45.8 -41.3 — — 2 BEARISH -54.5
NKTX Nkarta, Inc. $130M -1.1 -38.8 -75.4 — — 1 BEARISH -8.0
MENS Jyong Biotech Ltd. Ordinary Shares $130M — — — — — — BEARISH -97.0
AVXL Anavex Life Sciences Corp. $120M -4.9 -23.6 411.7 — — 2 BEARISH -85.3
UNCY Unicycive Therapeutics, Inc. $110M -2.1 -101.1 349.9 — — 4 BEARISH -26.3
CBUS Cibus, Inc. $110M -0.8 -225.9 -157.2 -2227.9 -10.3 2 BEARISH -11.4
LENZ LENZ Therapeutics, Inc. $100M -0.8 -59.2 17313.3 -581.8 329.5 3 BEARISH -90.0
ORPOF OSE Immunotherapeutics S.A. $100M — — — — — — BEARISH —
TNYA Tenaya Therapeutics, Inc. $90M -0.7 -121.9 1769.3 -3909.3 — 3 BEARISH -75.7
TNXP Tonix Pharmaceuticals Holding Corp. $90M -0.4 -81.8 -276.2 -299.4 196.0 3 BEARISH -71.5
CNXU Conexeu Sciences Inc. $90M — — — — — — BEARISH —
CRBP Corbus Pharmaceuticals Holdings, Inc. $80M -0.6 -95.6 738.2 — — 1 BEARISH -77.0
MIST Milestone Pharmaceuticals Inc. $80M -1.0 -35522.6 587.8 -5118.8 — 5 BEARISH -67.0
JWCTF JW (Cayman) Therapeutics Co. Ltd $80M -2.3 -49.0 -68.1 -45.3 60.7 3 BEARISH -55.3
PMN ProMIS Neurosciences, Inc. $70M -0.6 -172.3 844.3 — — 2 BEARISH -24.9
MAIA MAIA Biotechnology, Inc. $70M -1.9 -218.7 330.4 — — 3 BEARISH -24.0
CGTX Cognition Therapeutics, Inc. $70M -3.9 -83.8 6061.8 — — 3 BEARISH -59.1
CRBU Caribou Biosciences, Inc. $60M -0.4 -78.3 -695.0 -1619.9 10.0 3 BEARISH -80.3
TLSA Tiziana Life Sciences Ltd $60M -4.3 -780.6 375.0 — — 1 BEARISH -53.6
GOSS Gossamer Bio, Inc. $60M -0.2 178.7 117.2 182.9 32.4 3 BEARISH -94.5
HBPCF Helix BioPharma Corp. $60M -23.6 -50.8 -21.5 — — 3 BEARISH -55.5
INO Inovio Pharmaceuticals, Inc. $60M -0.8 -409.9 257.7 — -100.0 1 BEARISH -61.3
VTIAF FamiCord AG $50M -6.4 -84.3 -13.6 -5.1 0.1 5 BEARISH -43.6
PLRX Pliant Therapeutics, Inc. $50M -0.6 -50.3 -438.3 — — 3 BEARISH -51.4
GANX Gain Therapeutics, Inc. $50M -2.4 -268.3 1288.8 — — 4 BEARISH -41.6
HYFT MindWalk Holdings Corp. $50M -4.4 -123.5 -481.3 -158.7 -15.9 4 BEARISH -25.3
DWTX Dogwood Therapeutics, Inc. $40M -0.1 -47.8 -39.7 — — 2 BEARISH -80.2
ALDX Aldeyra The $40M -1.6 -49.5 269.3 — — 4 BEARISH -87.5
RANI Rani Therapeutics Holdings, Inc. $40M -2.2 -179.1 245.5 -432.7 306.4 5 BEARISH -70.8
IGC IGC Pharma, Inc. $30M -3.0 -129.2 -127.6 -1107.9 -15.4 1 BEARISH -33.7
FLNA Filana Therapeutics, Inc. $30M -0.7 -13.5 38.9 — — 2 BEARISH —
IXHL Incannex Healthcare Limited $30M -2.4 -31.9 5284.2 — -100.0 4 BEARISH -74.5
MCRB Seres Therapeutics, Inc. $20M -0.8 -66.6 -87.8 622.4 — 3 BEARISH -88.8
ATYR aTyr Pharma, Inc. $20M -0.2 -98.4 -1890.1 — — 2 BEARISH -84.2
TCRX TScan Therapeutics, Inc. $10M -0.2 -95.8 -159.4 -2888.6 2.2 2 BEARISH -91.9
RDTCF Rapid Dose Therapeutics Corp. $10M -4.2 49.3 80.2 -86.2 4.3 4 BEARISH -58.4
GUTS Fractyl Health, Inc. $10M -0.1 1063.0 -568.7 — -100.0 5 BEARISH -93.5
TPST Tempest Therapeutics, Inc. $10M -0.1 -931.1 -564.2 — — 1 BEARISH -95.1
HIND Vyome Holdings, Inc. $10M -0.1 -193.1 516.3 -2543.3 -98.0 4 BEARISH -68.7
ACTU Actuate Therapeutics Inc $10M -0.4 2457.6 541.3 — — 3 BEARISH -92.7
QNRX Quoin Pharmaceuticals, Ltd. $10M -0.3 -578.6 221.3 — — 1 BEARISH -70.1
NCNA NuCana plc $10M -0.3 -70.7 -739.9 — — 4 BEARISH -75.2
GSGTF GenSight Biologics S.A. $10M -1.0 46.5 47.3 1190.6 -401.7 3 BEARISH -57.9
INTS Intensity Therapeutics, Inc. $10M -0.7 -195.9 4123.4 — — 5 BEARISH -46.8
PXXLF Poxel S.A. $10M -0.4 34.8 129.6 -624.6 41.5 4 BEARISH -12.0
TOVX Theriva Biologics, Inc. $10M -0.3 -101.9 -213.5 — — 2 BEARISH -43.5
QNTM Quantum BioPharma Ltd. $10M -0.4 -425.3 175.1 — — 4 BEARISH -84.7
CDIO Cardio Diagnostics Holdings, Inc. $10M -0.6 -75.4 -230.9 -28012.5 -25.9 3 BEARISH -56.6
VTGN VistaGen Therapeutics, Inc. $10M -0.1 -166.5 851.1 -882.8 287.3 4 BEARISH -95.8
OPTBF OptiBiotix Health Plc $10M -1.4 -102.1 -102.1 -231.5 -12.9 4 BEARISH 109900.0
DARE Dare Bioscience, Inc. $10M -0.8 165.3 136.8 -1590.4 7816.7 3 BEARISH -69.2
RASP Actavia Life Sciences, Inc. — -0.1 20.1 14.5 — — 2 BEARISH -87.5
LIMN Liminatus Pharma, Inc. Class A Common Stock — -0.1 294.4 252.1 — — 4 BEARISH -95.5
NAVBQ Navidea Biopharmaceuticals, Inc. — — — — — — — BEARISH —
SUVZ Suvanza Pharma, LLC — — — — — — — BEARISH 0.0
HCWB HCW Biologics Inc. — -0.0 -133.5 -36.8 -3849.9 707.0 3 BEARISH -95.3
KAPA Kairos Pharma, Ltd. — -0.3 -114.0 -301.0 — — 3 BEARISH -93.0
GOVX GeoVax Labs, Inc. — -0.0 -891.6 1530.7 — -100.0 3 BEARISH -98.5
VBIO Valion Bio, Inc. — -0.0 -240.8 -48.0 — -281.4 2 BEARISH —
TNGNQ Tengion, Inc. — — — — — — — BEARISH 0.0
CELZ Creative Medical Technology Holdings, Inc. — -0.3 -78.0 8335.2 — -50.0 2 BEARISH -82.2
ENDV Endonovo Therapeutics, Inc. — -0.2 9.2 4.5 — -100.0 3 BEARISH -99.3
VPRO Viropro Inc. — -0.0 -19.7 -4.8 -269.7 155.0 2 BEARISH 0.0
ZVSA ZyVersa Therapeutics, Inc. — -0.0 817.1 242.0 — -100.0 1 BEARISH -99.3
EVFM Evofem Biosciences, Inc. — -0.1 20.1 26.0 -419.1 4.5 2 BEARISH -30.7
NBRVF Nabriva Therapeutics plc — — — — — — — BEARISH 0.0
KALA KALA BIO, Inc. — -0.0 -345.3 -913.5 — -100.0 4 BEARISH -99.5
WSNAF Wesana Health Holdings Inc. — -0.1 1113.6 90.8 — — 3 BEARISH -82.5
BNIGF Beroni Group Limited — -0.1 -1153.4 -274.8 -15945.7 40.9 5 BEARISH 0.0
SILO Silo Pharma, Inc. — -0.2 -91.2 645.1 — -25.0 3 BEARISH 107.8
ENLV Enlivex Therapeutics Ltd. — 0.0 209.7 -0.4 — — 5 BEARISH -99.0
EVGN Evogene Ltd. — -0.4 265.3 101.3 -509.5 -80.4 3 BEARISH -70.2
XENO Xeno Transplants Corporation — -0.0 -286.5 78.1 — — 1 BEARISH 0.0
ZHCLF Zenith Capital Corp. — -0.2 35107.2 37766.2 -360.0 — 3 BEARISH 3233.3
PMCB PharmaCyte Biotech, Inc. — -0.1 -44.0 793.8 — — 2 BEARISH -63.5
MLECW Moolec Science S.A. — -0.0 -174.7 -31.5 -91.8 170.4 3 BEARISH -27.4
GENSF Genus plc $1.8B 5.4 45.4 9.0 80.4 -3.8 5 BEARISH -19.4
MLYS Mineralys Therapeutics, Inc. $1.8B -4.9 -80.9 2274.6 — — 2 BEARISH -49.6
OCUL Ocular Therapeutix, Inc. $1.4B -4.7 -73.0 -31671.3 -584.5 -8.1 3 BEARISH -43.4
GPCR Structure Therapeutics Inc. $1.2B -7.1 -20.2 -1134.3 — — 3 BEARISH -20.6
SVRA Savara Inc. $870M -8.4 -105.5 -15438.9 — — 2 BEARISH 9.7
IVEVF Inventiva S.A. $750M -6.2 -988.4 -371.6 -347346.6 -99.7 3 BEARISH -22.8
ATTO Attovia Therapeutics, Inc. $630M -15.3 -294.4 -1137.2 -4597.1 -50.5 4 BEARISH 226.6
PROK ProKidney Corp. $470M -2.7 9.2 13.2 -18948.0 55.2 1 BEARISH -57.4
PHAT Phathom Pharmaceuticals, Inc. $460M -4.7 26.4 8.9 -23.7 110.2 4 BEARISH -56.4
FTH Faeth Therapeutics, Inc. $440M — — — — — — BEARISH —
RGNX REGENXBIO Inc. $440M -1.7 -137.6 -368.4 21.0 12.0 2 BEARISH -47.7
ALLO Allogene Therapeutics, Inc. $430M -1.9 -42.4 -81.9 -919.8 — 5 BEARISH 0.0
ALT Altimmune, Inc. $410M -2.6 -28.9 -43.1 — 55.0 4 BEARISH -47.0
ASMB Assembly Biosciences, Inc. $400M 37.0 -0.0 56.2 -28.8 125.1 4 BEARISH -28.5
TECX Tectonic Therapeutic, Inc. $390M -4.5 -33.8 -6371.3 — — 1 BEARISH 14.7
AVTX Avalo Therapeutics, Inc. $370M -1.4 -36.3 -148.4 — -86.6 4 BEARISH -62.2
CAPR Capricor Therapeutics, Inc. $340M -2.5 -73.7 -107.5 — -100.0 3 BEARISH -6.4
KYTX Kyverna Therapeutics, Inc. $330M -1.9 -87.2 14267.8 — — 2 BEARISH -17.7
FULC Fulcrum Therapeutics, Inc. $280M -3.1 -32.4 2389.1 — — 4 BEARISH -59.3
CTNM Contineum Therapeutics, Inc. $270M -5.2 -28.0 -541.6 — — 4 BEARISH -26.8
ACIU AC Immune S.A. $250M -4.2 -78.5 96.7 12.4 -39.5 2 BEARISH -17.8
ABEO Abeona Therapeutics Inc. $250M -3.9 -43.1 -5983.3 -177.4 6280.0 2 BEARISH -20.5
CABA Cabaletta Bio, Inc. $250M -0.9 -93.2 -1308.0 — — 3 BEARISH -44.0
SCTX Scribe Therapeutics Inc. $250M — — — — — — BEARISH —
OCGN Ocugen, Inc. $250M -2.9 1211.7 190.2 -1671.8 -3.7 2 BEARISH -53.0
PALI Palisade Bio, Inc. $230M -2.3 -51.4 815.6 -2114.8 — 5 BEARISH -30.5
NAGE Niagen Bioscience Inc $190M 12.9 21.8 44.7 3.2 11.0 6 BEARISH -67.1
IVVD Invivyd, Inc. $180M -1.5 -95.9 -302.5 -310.8 26.3 2 BEARISH -70.0
SION Sionna Therapeutics, Inc. $160M -1.8 -32.3 -137.7 — — 0 BEARISH -90.7
UPB Upstream Bio, Inc. $150M -1.0 -46.0 -1266.4 -5136.1 49.2 3 BEARISH -84.1
STRO Sutro Biopharma, Inc. $150M -0.5 266.8 43.6 -391.6 -56.3 4 BEARISH -16.1
CNTN Canton Strategic Holdings Inc $150M -1.2 -14.6 -7.2 -1287.2 — 2 BEARISH —
CMPX Compass Therapeutics, Inc. $140M -1.8 -56.7 1526.3 — — 4 BEARISH -80.8
VYGR Voyager Therapeutics, Inc. $110M -1.0 -54.1 -131.1 -773.2 -19.1 2 BEARISH -61.5
NERV Minerva Neurosciences, Inc. $110M -0.1 337.5 10.0 — — 1 BEARISH -54.8
VTVT vTv Therapeutics Inc. $100M -236.4 -11.7 91.2 — 216600.0 4 BEARISH 23.9
CLLS Cellectis S.A. $100M -1.7 -94.6 118.6 -417.3 0.5 2 BEARISH -73.2
ENGN enGene Holdings Inc. $100M -5.6 -2.3 134.1 — -100.0 2 BEARISH -79.9
GNLX Genelux Corporation $90M -2.2 -168.9 20537.7 — — 2 BEARISH -75.2
CRDF Cardiff Oncology, Inc. $70M -1.5 -94.1 443.4 -8876.9 -7.0 3 BEARISH -63.6
PTHS Pelthos Therapeutics Inc. $70M -0.3 4767.3 -97.0 -150.1 — 2 BEARISH -55.4
VRCA Verrica Pharmaceuticals Inc. $60M -2.0 473.3 437.4 -224.4 106.2 5 BEARISH -13.4
XBIT XBiotech Inc. $60M -1.3 -29.9 -201.2 — — 2 BEARISH -26.0
IBIO iBio, Inc. $50M -2.3 -65.7 21688.6 — -75.0 4 BEARISH -44.3
RNTX Rein Therapeutics Inc. $50M -0.4 -753.6 53.9 — — 3 BEARISH -53.7
EXOZ eXoZymes, Inc. $40M -3.3 -187.2 913.0 — — 2 BEARISH -69.0
VERU Veru Inc. $40M -3.8 -62.3 -211.2 — -100.0 3 BEARISH -40.6
ANVS Annovis Bio, Inc. $40M -0.6 -703.7 170.2 — — 1 BEARISH -52.6
KLRS Kalaris Therapeutics Inc $40M -0.9 -79.9 109.5 — — 0 BEARISH -63.2
ACET Adicet Bio, Inc. $40M -0.3 -78.1 -553.5 — — 4 BEARISH -71.4
TIL Instil Bio, Inc. $40M -1.3 -25.3 -69.1 — — 4 BEARISH -70.7
MREO Mereo BioPharma Group plc $40M -1.6 -67.8 6194.3 — -100.0 2 BEARISH -86.2
ALGS Aligos Therapeutics, Inc. $30M -0.7 -113.6 -1246.4 -5.4 893.0 2 BEARISH -51.0
EDSA Edesa Biotech, Inc. $30M -1.6 -122.9 759.6 — — 1 BEARISH -3.7
AARD Aardvark Therapeutics, Inc. Common Stock $30M -0.4 -66.0 -3642.4 — — 1 BEARISH -90.0
BSEM BioStem Technologies, Inc. $30M -0.9 -74.7 -84.3 -113.6 -119.6 2 BEARISH -68.3
NRXBF NurExone Biologic Inc. $30M — — — — — — BEARISH —
EYPT EyePoint Pharmaceuticals, Inc. $30M -0.1 -148.7 -3014.8 -18633.1 -94.6 2 BEARISH -96.8
BCTX BriaCell Therapeutics Corp. $30M -0.3 -179.9 -2435.2 — — 2 BEARISH -73.4
MGX Metagenomi, Inc. Common Stock $30M -0.3 -60.6 -268.2 10693.4 -59.8 1 BEARISH -72.4
GRCE Grace Therapeutics, Inc. $30M -1.4 -38.4 -58.9 — — 2 BEARISH -42.5
BXPHF Botanix Pharmaceuticals Limited $20M -0.3 -96.3 -131.6 -203.1 495.6 4 BEARISH -89.6
KYNB Kyntra Bio, Inc. $20M 0.1 -115.2 29.6 -812.3 — 2 BEARISH —
MVMDF More Life Company Corp. $20M -5.2 -167.0 -602.2 -5006.5 43.0 4 BEARISH 119.2
MSLE Satellos Bioscience Inc. $10M — — — — — — BEARISH —
FBLG FibroBiologics, Inc. Common Stock $10M -0.2 -660.1 -511.6 — — 4 BEARISH -88.9
INAB IN8bio, Inc. $10M -0.5 -111.1 -576.1 — — 4 BEARISH -54.0
APRE Aprea Therapeutics, Inc. $10M -0.5 -47.4 378.1 — -99.8 2 BEARISH -71.6
PTN Palatin Technologies, Inc. $10M -0.9 -877.5 1176.9 -1449.1 — 5 BEARISH -18.3
AIMD Ainos, Inc. $10M -0.3 -196.3 -69.4 -3022849.3 -87.7 1 BEARISH -78.4
TRAW Traws Pharma, Inc. $10M -0.7 -711.4 133.9 — -100.0 1 BEARISH -87.0
BCDA BioCardia, Inc. $10M -1.2 -1803.2 519.4 — — 3 BEARISH -35.6
ACXP Acurx Pharmaceuticals, Inc. $10M -0.3 -128.1 241.9 — — 3 BEARISH -83.2
BLRX BioLineRx Ltd. $10M -1.1 -63.5 -113.0 -1029.3 -94.3 3 BEARISH -45.1
MTVA MetaVia Inc. $10M -0.3 -175.7 209.3 — — 0 BEARISH -88.5
TVRD Tvardi Therapeutics, Inc. $10M -0.3 -126.2 296.9 — — 1 BEARISH -83.7
GTBP GT Biopharma, Inc. $10M -0.1 -798.9 927.8 — — 2 BEARISH -72.2
PHIO Phio Pharmaceuticals Corp. $10M -0.6 -113.7 2701.6 — — 2 BEARISH -60.3
RVPH Reviva Pharmaceuticals Holdings, Inc. $10M -0.1 -32.2 45.6 — — 4 BEARISH -25.0
CODX Co-Diagnostics, Inc. — -0.0 -174.8 -218.8 -3782.4 -28.1 3 BEARISH -94.5
FAMDF Futura Medical plc — -0.3 -145.8 -370.5 -72.8 -70.7 2 BEARISH -88.2
PPBT Purple Biotech Ltd. — -0.0 -111.3 -99.1 — — 2 BEARISH 75.0
GNPX Genprex, Inc. — -0.0 -203.9 3484.8 — — 4 BEARISH -99.1
OGEN Oragenics, Inc. — -0.1 -1307.1 4273.7 — — 3 BEARISH -68.9
LABT Lakewood-Amedex Biotherapeutics, Inc. — — — — — — — BEARISH —
MBAI MBody AI Ltd. — — — — — — — BEARISH —
DCOY Decoy Therapeutics Inc. — — — — — — — BEARISH —
NSHSF NanoSphere Health Sciences Inc. — 9.5 4.6 11.1 — — 0 BEARISH 0.0
ELAB PMGC Holdings Inc. — -0.0 -73.0 -66.6 -225.1 408.6 3 BEARISH -100.0
VRXAW Veraxa Biotech AG — — — — — — — BEARISH —
CLDI Calidi Biotherapeutics, Inc. — -0.0 -713.6 -1404.6 — — 4 BEARISH -97.4
MBIO Mustang Bio, Inc. — -0.8 -58.1 36.6 — — 2 BEARISH -75.0
SCPX Scorpius Holdings, Inc. — -0.0 0.0 0.0 -428.3 -75.5 0 BEARISH -66.7
MDCX Medicus Pharma Ltd. Common Stock — -0.0 -3904.0 -693.1 — — 3 BEARISH -97.9
NRSN NeuroSense Therapeutics Ltd. — -0.3 779.3 571.3 — — 3 BEARISH -89.7
ZLDAF Zelira Therapeutics Limited — -1.6 80.8 147.8 -185107971.7 -99.3 1 BEARISH -15.5
CANF Can-Fite BioPharma Ltd. — -0.3 -184.2 353.7 -2277.7 -40.1 2 BEARISH -82.4
CRIS Curis, Inc. — -0.0 455.3 -23281.0 — -62.2 3 BEARISH -98.8
NIKI Niki BioSolutions, Inc. — — — — — — — BEARISH —
OXBOF Oxford BioDynamics Plc — -0.3 -214.9 -155.8 -649.8 33.6 3 BEARISH -85.9
XSNX NovAccess Global Inc. — -0.0 27.7 18.0 — — 3 BEARISH 0.0

Profile Radar

Valuation vs Profitability

Performance Comparison

Industry Market Share

INMB vs Benchmarks

ROIC
INMB
-475.4
Industry
10.0
Revenue Growth
INMB
-100.0
Sector
0.8
P/E Ratio
INMB
-2.2
Sector
17.0
ROE
INMB
-74.8
Sector
-70.3
Piotroski F
INMB
2.0
Sector
3.0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms